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ABSTRACT 
The focus of this study was to characterise the nonsense-mediated mRNA decay (NMD) complex and 
its link to mRNA 3’ tagging in Aspergillus nidulans. The human histone H2a and H3 encoding 
transcripts were the first mRNAs reported to be oligouridylated. This was shown to involve Upf1, 
which is recruited by the stem-loop binding protein (SLBP) in response to DNA synthesis being 
blocked; Upf1 recruitment promotes 3’ tagging of the histone transcript which in turn leads to their 
rapid degradation. Other NMD components have not been implicated in the regulatory response. 
Initial work looking at the H2A transcript suggested that a similar response occurs in A. nidulans 
when DNA synthesis is blocked. In addition to the tagging factors, CutA and CutB, we tested a 
number of key NMD and decay factors to obtain a general view of histone mRNA regulation with the 
aim of gaining crucial information on the mechanism and function of tagging. Additionally, we 
investigated the role of two putative NMD factors, Smg6 and Upf3, and the specific role of particular 
domains within Smg6 and Upf1. Our studies confirmed that both Smg6 and Upf3 are required for 
NMD in A. nidulans. Additionally, we have shown that both Dcp2 mediated decapping and Smg6 
dependent endonuclease cleavage contribute to NMD in A. nidulans, similar to the situation in 
mammalian systems. Disruption of the NMD component Upf1, Upf2, Upf3 and Smg6 fully supress 
NMD and partially supress histone regulatory response to hydroxyurea treatment. Simultaneous 
disruption of certain NMD and decay factors displayed additivity and led to full disruption of histone 
mRNA regulation. Based on our data, one important possibility is the parallel function of the Lsm1-7 
activated decapping pathway and a second pathway involving the NMD complex but not Smg6 
mediated mRNA cleavage. Histone mRNA degradation data demonstrated that the disruption of 
CutA and CutB had a minor impact on histone mRNA regulation, whereas their disruption had a 
major impact on histone transcripts within polysomes. Western analysis demonstrated that both 
CutA and CutB were associated with ribosomal fractions. This Suggests that the CutA and CutB 
enzymes are involved in regulating translationally active histone transcripts and their disruption 
results in extension of histone mRNA half-life within the polysomes. However, this does not have a 
major effect on the overall histone mRNA turnover. These results are consistent with a model in 
which the tagging factors may recruited to transcripts harbouring a terminating ribosome possibly by 
Upf1. Subsequently, both the NMD components and engagement of the Lsm1-7 complex separately 
facilitate histone mRNA decapping and translational repression. 
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Chapter 1: Introduction 
1.1  Gene expression 
Gene expression is the process by which genetic information is transmitted, primarily 
through the synthesis of proteins, for cell maintenance, growth, proliferation, and 
differentiation. There are two key steps involved in making a protein; transcription and 
translation. Transcription of protein coding genes is when the genetic information encoded 
in DNA is transcribed by RNA polymerase. In eukaryotes this is mediated by RNA polymerase 
II, producing a primary transcript that undergoes various co- and post-transcriptional 
modifications to form the mature messenger RNA (mRNA). Translation in eukaryotes occurs 
after transcription is complete and the mRNA has been exported from the nucleus, the 
ribosomes completing the flow of information from the DNA by decoding the RNA to 
protein (Li and Xie, 2011). To live, cells must be able to control both transcriptional and 
translational patterns in order to adjust the quantity and nature of proteins it manufactures 
(Miller and Pearce, 2014). Although the primary component of gene regulation occurs at the 
level of transcriptional initiation, cells also regulate protein levels through the enzymatic 
breakdown of RNA transcripts and existing protein molecules that it no longer needs or that 
are detrimental to its health (Miller and Pearce, 2014). In addition, faulty or damaged 
proteins are recognised and rapidly degraded within cells, thereby eliminating the 
consequences of mistakes made during protein synthesis (Cooper, 2000). 
 
1.2  mRNA maturation 
In eukaryotic cells, newly transcribed mRNA is initially modified by adding specific structures 
at its ends; the 5’ terminal 7-methylguanosine (m7G) cap and the 3’ terminal poly(A) tail 
(Zhao et al., 2017). Modifying the transcript is required to permit mRNA transfer from the 
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nucleus to the cytoplasm for subsequent rounds of translation (Zhao et al., 2017). The m7G-
cap structure protects the mRNA from 5′-3′ exonucleolytic degradation, it is recognised and 
bound by the cap-binding protein, eukaryotic translation initiation factor 4E (eIF4E) (Zhao et 
al., 2017). The mRNA poly(A) tail, which is a vulnerable to 3’-5’ exonuclease activity of the 
deadenylases and the exosome, is protected by poly(A) binding protein (Pab1) (Dunn, 2005). 
 
The eukaryotic genes are discontinuous as they contain protein coding regions (exons) 
disrupted by noncoding regions (introns) (Lee and Rio, 2015). The introns are spliced out by 
the spliceosome from the precursor messenger RNA (pre-mRNA) to join protein coding 
exons into mature mRNA (da Costa, Menezes and Romão, 2017). Vertebrates have relatively 
long introns and short exons; this relationship is reversed in lower eukaryotes (Li, Xu and 
Ma, 2017). Eukaryotes have lost and gained introns in response to strong selective pressures 
over time as part of their dynamic intron evolution (Li, Xu and Ma, 2017). It was suggested 
that natural selection favours short introns in the highly expressed genes of nematodes and 
humans to minimise the cost of transcription (Li, Xu and Ma, 2017). However, the density of 
introns in a gene does not show a strong correlation with the level of gene expression. 
However, it was found that organisms that reproduce rapidly have a lower intron density 
than organisms with longer life cycles (Li, Xu and Ma, 2017). For instance, Homo sapiens 
have an average of 8.1 introns per gene, Caenorhabditis elegans with 4.7, Arabidopsis 
thaliana with 4.4 and Drosophila melanogaster with 3.4; whereas unicellular species with 
short life spans were found to have fewer introns (Stajich, Dietrich and Roy, 2007). Studies 
of intron densities in a variety of single-celled species have revealed great variation. For 
instance, the yeasts Schizosaccharomyces pombe and Saccharomyces cerevisiae have low 
intron densities with 0.9 and 0.05 introns per gene, respectively. However, the 
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euascomycete fungi Neurospora crassa and Aspergillus nidulans have much higher intron 
densities at 2-3 per gene (Stajich, Dietrich and Roy, 2007). 
 
With advances in genome sequencing, it is apparent that organismal complexity is to a great 
extent dependent on the pre-mRNA splicing (Lee and Rio, 2015). Although the numbers of 
genes in mouse and human genomes are similar, alternative pre-mRNA splicing (AS) occurs 
in approximately 63% of mouse genes compared with 95-100% of human genes (Lee and 
Rio, 2015). Therefore, one characteristic of AS is to expand the form and function of the 
proteome by creating multiple transcript variants produced from a single gene locus (Lee 
and Rio, 2015). It has been reported AS can function in several modes such as exon skipping 
and alternative use of 5′ and 3′ splice sites which regularly occur whereas more rare events 
such as intron retention and the inclusion of mutually exclusive exons can also take place 
(da Costa, Menezes and Romão, 2017). AS participates in various biological processes, such 
as metabolism, diﬀerentiation, pluripotency, adhesion, cell proliferation, adaptation and 
apoptosis; in contrast its aberrant activation can lead to many human diseases such as 
various types of cancers (da Costa, Menezes and Romão, 2017). 
 
In mammalian, during splicing a multiprotein assembly termed the exon junction complex 
(EJC) is loaded 20-24 nucleotides upstream of the exon-exon junctions by the splicing 
machinery (Figure 1.1) (Hir, Saulière and Wang, 2015). The EJC is composed of an inner 
heterotetrameric core consisting of eIF4A3, MAGOH, Y14 and MLN51 (Tian et al., 2017). 
The EJC core components are linked to the mRNA via eIF4A3 which is a DEAD-box RNA 
helicase (Bhuvanagiri et al., 2010). eIF4A3 binding to the Y14–MAGOH dimer inhibits its 
ATPase activity and stabilises the binding of EJC components to the mRNA (Bhuvanagiri et 
 
 
 
 
4 
al., 2010). EJC core components are accompanied with other regulatory factors which 
remain associated with mRNA until translation (Tian et al., 2017). The composition of EJCs 
is highly dynamic, where the EJC core factors act as a binding platform for a number of 
proteins called the EJC peripheral factors; these promote EJC functionality during mRNA 
transport to the cytoplasm (Hir, Saulière and Wang, 2015, Bhuvanagiri et al., 2010). In the 
cytoplasm, the EJC acts as an anchor for various mRNA processing factors during translation 
(Hir, Saulière and Wang, 2015). 
 
Translation begins with the recognition of the cap structure by the eIF4E protein;  eIF4G 
then serves as a scaffolding protein to recruit other translation initiation factors such as 
eIF4A, eIF4B and Pab1 to form the eIF4F complex (Hir, Saulière and Wang, 2015, González-
Almela et al., 2018). 
 
The interactions between mRNA 5’ end through eIF4G and mRNA 3’ end through Pab1 
results in a closed-loop conformation which has been shown to be important for the 
translation initiation (von der Haar, Ball and McCarthy, 2000). Upon the formation of the 
eIF4F complex, the small 40S ribosomal subunit carrying additional initiation factors; eIF1, 
eIF1A, eIF3, eIF5 and the ternary complex eIF2-Met-tRNAi
Met-GTP forms the 43S pre-
initiation complex (González-Almela et al., 2018). Subsequently, the 43S pre-initiation 
complex interacts with the 5′ end of the mRNA forming the 48S initiation complex which 
scans mRNA from 5′ to 3′ until it detects the start codon in an appropriate sequence context 
(Langley, 2015). Finally, eIF5B binds the 48S complex which promotes the release of eIFs in a 
GTP-dependent manner, resulting in a fusion with the large 60S ribosomal subunit to form 
the elongating 80S ribosome (González-Almela et al., 2018). 
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Through the pioneer round of translation the translating ribosome subsequently displace 
EJCs on the transcript (da Costa, Menezes and Romão, 2017). However, when the mRNA 
molecule is defective, the ribosome will fail to displace these distal EJCs and consequently 
results in the formation of a decay-inducing complex (da Costa, Menezes and Romão, 2017). 
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Figure 1.2  The assembly of EJCs on mRNA. In 
human cells, following splicing, the EJCs are 
assembled on the spliced mRNA by the 
spliceosome. EJC peripheral factors restricted 
to the nucleus leave the EJC before the mRNP 
enters the cytoplasm through the nuclear pore 
complex (NPC). Several factors involved in 
mRNA splicing, transport, translation and 
processing along with the EJC core proteins; 
eIF4A3, MAGOH, Y14 and MLN51 remain 
associated with the mRNP. Once in the 
cytoplasm, Upf2 joins the EJC whereas the 
nuclear transport factors; ALYREF, NXF1 and 
NXT1 dissociate rapidly. In cytoplasm, 
untranslated mRNAs bound by cap-binding 
complex (CBC) and nuclear poly(A) binding 
protein (PABPN) are exchanged with the 
translation initiation factors eIF4E and PABPC, 
respectively. Circularisation of the mRNA 
through the interaction of PABPC with 
translation factors bound at the cap facilitates 
successive rounds of translation. Following EJC 
disassembly and SR protein release, eIF4A3 
and MLN51, as well as SR proteins, can 
potentially rebind to translated mRNAs or 
shuttle back to the nucleus. PYM has been 
identiﬁed to mediate efﬁcient EJC components 
disassembly and recycling. Figure taken from 
Hir, Saulière and Wang, (2015). 
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1.3  General mechanism of mRNA decay 
The balance between mRNA synthesis and decay adjusts transcript abundance to the needs 
of the cell for specific proteins (Braun and Young, 2014). Previous studies have revealed that 
the two processes are closely related (Braun and Young, 2014). Transcript decay is a major 
component of overall mRNA metabolism and plays a key role in determining intracellular 
levels of mRNA molecules under certain stress conditions or when the transcript is defective 
(Deutscher, 2006). Significant advances have been made in our knowledge of the mRNA 
regulatory mechanism over the past 20 years (Kiledjian, 2015). In all organisms tested from 
all kingdoms of life, mRNA degradation is a prevalent activity. Overall, the emerging picture 
is that despite the immense complexity of specific mRNA degradation pathways, there are 
substantial similarities in mechanisms of mRNA degradation between bacteria, archaea, and 
eukaryotes, underlining its major, and long-standing, importance (Houseley and Tollervey, 
2009). 
 
Although the general pathways of mRNA decay remain constant, many of the key 
endo/exonucleases and trans-acting factors have been identified and found to be highly 
conserved across eukaryotes (Table 1) (Houseley and Tollervey, 2009). Several deadenylases 
have been uncovered; PARN, Pan2/Pan3 and the CCR4/Caf1/Not complex, all functioning to 
remove the 3′ end poly(A) tail (Houseley and Tollervey, 2009). Subsequently, the 
deadenylated mRNA can be efficiently degraded by the exosome complex. This complex 
consists of a core of nine subunits arranged in a ring-like structure, with 3′-5’ exonuclease 
activity; associated with several ribonucleases such as PM/Scl-100 (Rrp6 in Saccharomyce 
cerevisiae) or Rrp44 (Dis3 in S. cerevisiae) proteins (Houseley and Tollervey, 2009). In 
addition to the decay of the mRNA from the 3′ end the 5’ cap structure can be removed by 
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the cytoplasmic decapping complex which is composed of the catalytic subunit Dcp2 and its 
coactivator, Dcp1 (Houseley and Tollervey, 2009). Additionally, several enhancers of 
decapping in humans, such as PatL1 (Pat1 in S. cerevisiae), DDX6 (Dhh1 in S. cerevisiae), 
Edc3, Scd6 and the Sm-like (Lsm) protein complex (Lsm1-7) are thought to modulate its 
decapping activity in vivo (Antic et al., 2015). Once the cap is removed, the 5′ end is 
degraded by the exonuclease Xrn1 (Houseley and Tollervey, 2009). In some circumstances, 
mRNA degradation is initiated by endonucleolytic cleavage. Internal cleavage produces free 
5’ and 3’ ends, which in turn can be degraded by Xrn1 and/or the exosome, respectively 
(Houseley and Tollervey, 2009). 
 
The absence of any one mRNA degradation factor does not commonly result in a complete 
inhibition to mRNA degradation in either eukaryotes or prokaryotes (Houseley and 
Tollervey, 2009). This signifies that multiple proteins are able to identify the same target 
transcripts and compensate for the deleted protein, which enhances the robustness of 
mRNA degradation (Houseley and Tollervey, 2009). 
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Table 1  mRNA decay factors. List of major proteins involved in general mechanisms of NMD and 
mRNA decay in eukaryotes. 
 Protein Function Reference 
3’ tagging    
 CutA A nucleotidyltransferase that catalyses the addition of nucleotides 
(C/U) to the 3′ end of mRNA in A. nidulans. Putatively forming a 
complex with CutB. 
 
(Morozov et al., 2012) 
 CutB A nucleotidyltransferase that catalyses the addition of nucleotides 
(C/U) to the 3′ end of mRNA in A. nidulans. Putatively forming a 
complex with CutA. 
(Morozov et al., 2012) 
NMD    
 Upf1 A 5’-3’ DNA and RNA helicase with nucleic acid-dependent ATPase 
activity essential for NMD, competing with Pab1 for interaction with 
eRF3.  
 
(Azzalin and Lingner, 2006) 
 Upf2 Involved in both mRNA nuclear export and mRNA surveillance. 
 
(Melero et al., 2014) 
 Upf3 A part of a post-splicing multi-protein complex involved in both 
mRNA nuclear export and mRNA surveillance. 
 
(Melero et al., 2014) 
 Smg6 Is thought to provide a link to the mRNA degradation machinery as it 
has endonuclease activity required to initiate NMD. 
 
(Nicholson et al., 2014) 
 
Decay    
3’-5’ decay Ccr4 3’-5’ exonuclease, a catalytic subunit of deadenylase complex. 
 
(Laribee et al., 2015) 
 Caf1 3’-5’ exonuclease, a catalytic subunit of deadenylase complex. 
 
 
 Rrp44 The catalytically active component of exosome complex involved in 
both an RNase II−like hydrolytic 3′-exonuclease activity and a PIN-
domain endonuclease activity. 
 
(Schneider et al., 2014) 
 Ski3 
 
An exosome enhancer. 
 
(Fromont et al., 2014) 
5’-3’ decay Dcp1 A subunit of decapping complex, the enzymatic activity of Dcp2 is 
critically dependent on the Dcp1. 
 
(Fillman and Lykke-
Andersen, 2005) 
 Dcp2 The catalytic subunit of the Dcp1:Dcp2 complex. 
 
(Fillman and Lykke-
Andersen, 2005) 
 Dhh1 A DEAD-box RNA helicase, an activator of mRNA decapping. It 
interacts with both decapping and deadenylase complexes. It binds 
to mRNA and also associates with Edc3 and Pat1. 
 
 
(Sesma and Haar, 2014) 
 Pat1 It appears to function as a scaffold protein to form a multisubunit 
assembly to activate mRNA decapping. It binds to Dhh1, Lsm1-7 
complex, Dcp1, Dcp2 and Xrn1. 
 
 
(Fourati et al., 2014) 
 Scd6 It associates with eIF4G subunit of eIF4F translation initiation 
complex. 
 
(Fromont et al., 2014) 
 Edc3 Sm-like, decapping enhancer. 
 
(Fourati et al., 2014) 
 Lsm1-7 A cytoplasmic heteroheptameric complex of Sm-like proteins, 
required for mRNA decapping. 
 
 
(Zhou et al., 2013) 
 Lsm2-8 A nuclear heteroheptameric complex of Sm-like proteins, required 
for mRNA splicing. 
 
(Zhou et al., 2013) 
 Xrn1 5’-3’ exonuclease degrades mRNA containing a free 5’ monophosphate end. (Harigaya and Parker, 2012) 
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1.4  Regulation of aberrant transcripts 
Gene expression is a controlled and monitored throughout the multi-step process of gene 
expression; from DNA to RNA to protein. In some cases, DNA damage can be repaired but 
aberrant mRNA and protein may not, thus a number of different mechanisms have evolved 
to detect and eliminate these aberrant gene products. In the case of mRNA synthesis, 
various defects can arise including somatic rearrangements at the DNA level and germ-line 
mutations, the latter accounting for hundreds of inherited genetic disorders, especially 
cancers (Chakrabarti et al., 2011). Additionally, errors can arise much more frequently 
during transcription and pre-mRNA splicing than in DNA replication (Allan Drummond and 
Wilke, 2009). In all organisms, DNA is duplicated with remarkable fidelity to ensure the 
faithful transfer of genetic information from one generation to the next through the 
combined action of accurate DNA polymerases and post-replication DNA mismatch repair, 
which result in a DNA mutation rate estimated to be lower than 1 × 10−9 per base pair (bp) 
(McCulloch and Kunkel, 2008). For example, it was found that the yeast transcriptome 
contains on average 4.0 errors per million base pairs. It was demonstrated that transcription 
errors are more than a 100 times more frequent. However, these errors are not equally 
distributed across the transcriptome. Transcripts synthesised by RNA polymerase II (RNAPII) 
contain the least number of errors (3.9 × 10−6 per bp), followed by ribosomal RNA molecules 
synthesised by RNAPI (4.3 × 10−6 per bp), mitochondrial RNA (9.3 × 10−6 per bp) and 
transcripts synthesised by RNAPIII (1.7 × 10−5 per bp); suggesting that each RNA polymerase 
has a unique error rate (Gout et al., 2017). 
 
Protein synthesis is the next step in gene expression; it is also the stage which harbours the 
greatest potential for errors (Mohler and Ibba, 2017). Translation in prokaryotic and 
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eukaryotic cells has an error rate in the range of 1 x 10−3 to 1 x 10−4 per bp, under normal 
physiological conditions, leading to the incorrect incorporation of amino acids into proteins 
(Araújo et al., 2018). Although, it was recently reported for bacterial cells, that 
mistranslation arises approximately once every 200 codons (Meyerovich, Mamou and Ben-
Yehuda, 2010). However, various mechanisms, such as molecular chaperones, proteasomes 
and autophagy, can remove defective proteins so that the cell usually does not suffer 
significant damage. However, defects in the translational machinery can lead to dysfunction 
or disease due to an increased level of errors (Araújo et al., 2018). 
 
Translation plays a significant role in the regulation of gene expression and is implicated in 
the control of cell growth, proliferation, and differentiation. In eukaryotes, during the first 
round of translation, transcripts containing premature termination codons (PTC) can be 
recognised and rapidly degraded via a surveillance pathway known as nonsense-mediated 
mRNA decay (NMD) which involves a series of protein-protein interactions (Chakrabarti et 
al., 2011). NMD is an evolutionarily conserved process and, for the most part, components 
of the NMD complex in mammalian cells have been identified by their homology to those in 
yeast or by their physical interaction to previously identified members of the NMD complex, 
emphasising the significance of this pathway in evolutionary terms (Gardner, 2010). 
 
Initially, it was discovered that the level of β-globin mRNA in patients with β0-thalassemia 
was repressed by NMD, subsequent studies in many species, have revealed that expression 
of between 4% and 25% of protein-coding genes are altered when NMD is reduced or 
eliminated (Muir, Gasch and Anderson, 2017). A consistent issue with such studies is the 
difficulty in determining whether the altered expression of any single gene in an NMD-
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deficient cell is either due to a direct effect of NMD or whether the altered expressions of 
NMD substrates have an indirect consequence on the mRNA of other genes. 
 
To establish whether a transcript is a direct substrate of NMD, a number of different 
strategies have been utilised (Muir, Gasch and Anderson, 2017) such as:  
 isolating transcripts that copurify with the NMD factors  
 measuring mRNA half-life after NMD inhibition, followed by monitoring immediate 
versus delayed effects on expression 
 measuring changes in mRNA abundance following reactivation of NMD  
Together, such studies have shown that around 20-50% of transcripts that have increased 
expression in NMD-deficient cells are direct NMD substrates (Muir, Gasch and Anderson, 
2017). Remarkably, the abundance of a number of transcripts, which appear to be 
substrates of NMD remains unchanged in NMD-deficient cells (Muir, Gasch and Anderson, 
2017).  
 
A key function of NMD is to prevent accumulation of non-functional or potentially harmful 
truncated proteins in the cell (Fiorini, Boudvillain and Le Hir, 2012). Consequently, NMD can 
reduce the phenotypic impact of a mutation. However, in cases where NMD silences an 
aberrant transcript that nevertheless has the potential to produce a functional product, 
NMD can exacerbate the effect. PTC-containing transcripts may evade NMD in two ways; by 
the incomplete action of NMD in the degradation of PTC-containing transcript or by a 
specific mechanism that allows the transcript to evade NMD to ensure protein synthesis 
(Smith, Blencowe and Graveley, 2008). For example, DMD (Duchenne muscular dystrophy) is 
a disorder which arises due to 5’ PTCs in the dystrophin gene prompting an NMD response 
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which drastically reduces the synthesis of the truncated protein. 3’ PTCs on the other hand 
are linked to a milder form of the disorder called BMD (Becker muscular dystrophy) since 
they can escape NMD and resulting in the synthesis of C-terminally truncated dystrophin 
protein (Bhuvanagiri et al., 2010). 
 
It was concluded that the augmentation or inhibition of NMD efficiency could offer potential 
therapeutic strategies and applications in medicine (Bhuvanagiri et al., 2010). In theory, 
NMD could be stimulated or inhibited for therapeutic results depending on its effect on 
target proteins. Although, only inhibition of NMD has been developed clinically against 
diseases which could be favourably affected by the increased synthesis of the mutated 
proteins. A much deeper understating of the NMD pathway and its manipulation are 
required in order to develop strategies that can modulate NMD as a therapeutic strategy for 
PTC-related inherited disorders (Han et al., 2017). 
 
NMD can significantly reduce the abundance of PTC-containing transcripts, but does not 
eliminate them completely (Smith, Blencowe and Graveley, 2008). Furthermore, PTC-
containing isoforms are not degraded immediately, their degradation occurs only after a 
pioneer round of translation, which may occur near the nuclear pore during or soon after 
export of the mRNA from the nucleus (Smith, Blencowe and Graveley, 2008). Therefore, PTC-
containing transcripts are present in the cell, especially inside the nucleus, due to the 
temporal lag between splicing and degradation rather than incomplete surveillance (Smith, 
Blencowe and Graveley, 2008). 
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The key NMD proteins are the three up frame-shift (Upf) suppressor proteins with Upf1 
acting as the central regulator of the NMD pathway, which is highly conserved across all 
eukaryotes. Upf1 is a phosphoprotein whose activity in multicellular organisms is regulated 
by cycles of phosphorylation and dephosphorylation. The four ‘’suppressor with 
morphological effect on genitalia’’ (Smg) proteins; Smg1, Smg5, Smg7 and Smg6 have been 
shown to mediate the phosphorylation/dephosphorylation cycles of Upf1 which allows the 
formation of an Upf1-Upf2-Upf3 surveillance complex that is believed to trigger the mRNA 
degradation machinery (Peccarelli and Kebaara, 2014). However, the detailed role of these 
Smg proteins and how they mediate Upf1 phosphorylation/dephosphorylation cycles is yet 
to be determined. 
 
A defining step in recruiting Upf1 and promoting NMD is the failure of two eukaryotic 
release factors, eRF1 and eRF3 to release ribosomes that terminate at a PTC (Singh, 
Rebbapragada and Lykke-Andersen, 2008). Typically, a number of ribosomes are 
engaged with the transcript in order to allow repeated rounds of translation. At the end of 
each round of translation, eRF3 is recruited by eRF1 to the translating ribosome as it 
associates with the termination codon. Generally, eRF3 interacts with poly(A) binding 
protein (Pab1), an interaction which promotes both deadenylation and the dissociation and 
recycling of ribosomes (Morozov et al., 2012). In the case of NMD the interaction between 
eRF3 and Pab1 does not occur and Upf1 is recruited to the terminating ribosome through an 
interaction with eRF3.  This can take place, for example, where there is a premature 
termination codon (PTC) positioned such that the poly(A) tail and associated Pab1 cannot 
easily associate with eRF3, and is exacerbated if there is an exon junction complex 3’ to the 
PTC.    
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Based on work in S. cerevisiae and mammals, deadenylation of transcripts to approximately 
fifteen adenine residues results in Pab1 dissociation (Parker, 2012). As the Pab1-eRF3 
interaction is central to ribosome recycling, it has been proposed that in the absence of 
Pab1, deadenylation will result in eRF3 recruiting of Upf1 to the stalled ribosome, which 
triggers an NMD-like response, leading to repression of translational initiation, mRNA 
decapping and degradation, all of which mirror the role of the NMD factors in regulating 
gene expression (Figure 1.2) (Morozov et al., 2012). However, no confirmation of this model 
or detailed understanding of NMD factors specificity for terminating ribosomes at 
termination codons is yet available. Additionally, the mechanisms and factors responsible 
for the recognition and dissociation of stalled ribosomes remain to be fully elucidated. 
 
The importance of the NMD components is highlighted by the fact that they not only impact 
on the expression of PTC-containing transcripts, but also play an important role in 
modulating the expression levels of a large number of genes (Ottens and Gehring, 2016). 
Moreover, under specific stress conditions, NMD components are important players in 
regulating the abundance of functional mRNAs. An example of this is the regulation of 
histone transcripts by Upf1 in response to repression of DNA synthesis in human cells 
(Mullen and Marzluff, 2008). 
 
In addition to NMD, two other mRNA surveillance pathways have also been discovered: 
non-stop decay (NSD) and No-Go decay (NGD). Like NMD, these both monitor mRNAs for 
translational errors to prevent the production of aberrant proteins. mRNAs that lack an in-
frame termination codon or exhibit stop codon read-through, leads to the ribosome 
translating the poly(A) tail and stalling at the 3’ end (Jamar, Kritsiligkou and Grant, 2017, 
 
 
 
 
16 
Krebs, Goldstein and Kilpatrick, 2017). Premature transcriptional termination and 
polyadenylation is the main source of NSD substrates (Krebs, Goldstein and Kilpatrick, 
2017).  
 
NSD substrates are targeted by a set of factors called the Super killer (Ski) proteins (Krebs, 
Goldstein and Kilpatrick, 2017). The ribosome is released from the mRNA by the action of 
Ski7 (Krebs, Goldstein and Kilpatrick, 2017). Ski7 has a GTPase domain similar to eRF3 and 
probably binds to the ribosome in the A site to stimulate release (Krebs, Goldstein and 
Kilpatrick, 2017). Ski7 promotes the subsequent recruitment of Ski complex proteins and the 
exosome, leading to 3’-5’ decay of the NSD substrates (Krebs, Goldstein and Kilpatrick, 
2017). The Ski complex is an evolutionarily conserved complex which consists of three 
proteins; this complex is functionally and physically associated with the exosome (Krebs, 
Goldstein and Kilpatrick, 2017). The three proteins that embody the Ski complex are the 
DExH RNA helicase, Ski2, a tricopeptide repeat protein, Ski3, and WD repeat protein, Ski8 
(Jamar, Kritsiligkou and Grant, 2017). Moreover, in the absence of Ski7 the decay of NSD 
substrates can proceed by decapping and 5’-3’ decay (Krebs, Goldstein and Kilpatrick, 2017). 
NSD substrate vulnerability to decapping could be due to the pioneer ribosome displacing 
PABPs as it penetrates the poly(A) tail (Krebs, Goldstein and Kilpatrick, 2017). Rrp44 also 
known as Dis3 is the catalytic subunit of the exosome which promotes both endonucleolytic 
and exonucleolytic digestion of NSD substrates (Shoemaker and Green, 2012). 
 
mRNAs can contain a range of potential stall-inducing characteristics such as rare codons, 
pseudoknots, GC-rich sequences, damaged RNA bases or strong secondary structures which 
can cause translating ribosomes to stall known NGD (Shoemaker and Green, 2012). NGD is 
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the least understood of the decay pathways (Krebs, Goldstein and Kilpatrick, 2017). NGD 
substrates are targeted by the recruitment of two proteins, Dom34 and Hbs1, which are 
homologous to eRF1 and eRF3, respectively (Saito, Hosoda and Hoshino, 2013). Therefore, 
Hbs1 is closely related to Ski7 and it is thought that it can function in both NSD and NGD 
(Jamar, Kritsiligkou and Grant, 2017). The Dom34–Hbs1 complex binds to the ribosome A 
site and promotes the dissociation of the stalled ribosomes (Jamar, Kritsiligkou and Grant, 
2017). NGD substrate decay is initiated by an endonuclease cleavage, it was suggested that 
Dom34 may be the active endonuclease involved in initiating decay, as one of its domains is 
nuclease like (Krebs, Goldstein and Kilpatrick, 2017). Subsequently, the 5’ and 3’ fragments 
are digested by the exosome and Xrn1, respectively (Krebs, Goldstein and Kilpatrick, 2017). 
 
Endonucleolytic cleavage has been implicated in all three NSD, NGD and NMD surveillance 
pathways. However, the factors responsible for the cleavage of NSD and NGD substrates are 
incompletely defined with the exception of Smg6 which has a defined role in the cleavage of 
NMD substrates (Shoemaker and Green, 2012). The endonucleolytic cleavage is a potent 
mechanism for triggering mRNA decay which circumvents the need for the normal initial 
steps in mRNA decay, decapping and deadenylation, which are typically rate limiting and 
tightly regulated (Shoemaker and Green, 2012). mRNA cleavage is likely to be an irreversible 
process (Shoemaker and Green, 2012). More studies are needed to uncover the role of the 
endonuclease cleavage involved in NSD, NGD and NMD pathways. 
 
1.5  mRNA 3’ end tagging 
The first reports of the addition of a short run of non-templated nucleotides to the 3’ end of 
cytoplasmic RNA molecules (termed 3’ tagging) were for small noncoding RNAs and their 
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degradation products in both animal and plant systems, where it was shown to be 
associated with degradation, maturation and the modulation of function (Shen, 2004). In 
prokaryotes, mRNA degradation is initiated by the addition of oligo (A) to the mRNA 3’ end 
and subsequent binding of Hfq protein, a homologue of the eukaryotic Sm-like proteins 
(Valentin-Hansen, Eriksen and Udesen, 2004). The human H2a and H3.3 histone encoding 
transcripts were the first mRNAs reported to be oligouridylated (Mullen and Marzluff, 
2008). This was shown to involve Upf1, which is recruited by the stem-loop binding protein 
(SLBP) in response to DNA synthesis being blocked. Upf1 recruitment promotes 3’ tagging of 
the histone transcript which in turn leads to their rapid degradation (Mullen and Marzluff, 
2008). Human histone transcripts are unusual in that they are not polyadenylated but the 
SLBP functionally replaces poly(A) binding protein (Mullen and Marzluff, 2008).  
 
Most mRNA uridylation events reported to date involve the addition of just one or two 
uridine monophosphate residues. It was shown that mRNA monouridylation is sufficient to 
promote decapping in a cell-free system; this stimulatory effect increased with longer 
oligo(U) tails, reaching a plateau between five and ten nucleotides (Song and Kiledjian, 
2007, Norbury, 2013). It remains to be determined whether increasing oligo(U) tail length 
similarly increases decapping efficiency in vivo (Norbury, 2013).   
Cytoplasmic deadenylation generally triggers the removal of the 5ʹ cap and exonucleolytic 
degradation of the residual body of the mRNA. Shortening of the poly(A) tail prevents PABP 
binding and favours recruitment of the Lsm-Pat1 complex, which preferentially binds short 
terminal oligo(A) and oligo(U) regions and stimulates decapping (Norbury, 2013). Following 
decapping, Xrn1 degrades the accessible 5’ end of the mRNA whilst the 3’ end is degraded 
by the exosome (Norbury, 2013).  
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mRNA decapping  is generally preceded by deadenylation, however this concept has been 
challenged by observation into the fission yeast S. pombe, where the poly(A) tail length of 
decapped act1 mRNA was similar to that of capped transcript (Rissland and Norbury, 2009). 
Similar to decapping in S. pombe, uridylation does not require prior deadenylation; loss of 
tagging in S. pombe resulted in mRNA stabilisation, which suggested the involvement of 
tagging in mRNA degradation (Norbury, 2013). Similar observations were made in A. 
nidulans where it was shown that prior deadenylation is also not required for either 
decapping or tagging in the presence of a PTC (Figure 1.2) (Morozov et al., 2012). 
 
These findings are consistent with observations in A. nidulans, including Upf1 regulated 
mRNA 3’ tagging of polyadenylated transcripts, which is mediated by CutA and CutB 
enzymes (Figure 1.2) (Morozov et al., 2012). It was demonstrated that disruption of either 
CutA or CutB led to a dramatic reduction in mRNA 3’ tagging and a significantly increased 
proportion of PTC-containing transcripts associated with ribosomes in A. nidulans (Morozov 
et al., 2012). No mRNA tagging was observed when both CutA and CutB were disrupted 
(Morozov et al., 2012). Additionally, in a ∆upf1 mutant strain, 3’ tagging of short poly(A) tails 
was reduced but not completely lost (Morozov et al., 2012). Regarding these observations, 
what remains unclear are the links between mRNA 3’ tagging and the factors mediating 
mRNA degradation in both the regulation of functional transcripts and the elimination of 
deadenylated or aberrant transcripts. 
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Figure 1.5  Translational termination of deadenylated transcripts promotes an NMD-like response. During 
translation the cap binding complex at the mRNA 5’–end associates with Pab1 associated with the 3’ poly(A) 
tail through an interaction mediated by eIF4G. This interaction is important for efficient translational initiation 
and ribosome recycling. Recruitment of eRF3 by eRF1 to terminating ribosome at NTC leads to interaction with 
Pab1 which is required for efficient ribosome dissociation and initiate new round of translation (A and B). 
Poly(A) tail degradation to approximately 15 adenine residues by Ccr4-Caf1-Not complex in A. nidulans is 
proposed to cause Pab1 dissociation resulting in eRF3 recruiting Upf1, triggering an NMD like response. In 
addition, Pab1 binding to long poly(A) tails prevents mRNA 3’ oligouridylation (Lim et al., 2014) by CutA and 
CutB in A. nidulans where tagging generally occurs in transcripts with short poly(A) tails (Morozov et al., 2012) 
(C and D). During NMD terminating ribosome at PTC recruits Upf1 through its interaction with eRF3, this 
triggers mRNA 3’ tagging which is known to help recruit the Lsm-Pat1 complex which is poly(A) independent (E 
and F). Although 3’ tagging is not required for NMD-induced transcript degradation, its loss leads to decapping 
becoming dependent on deadenylation. Figure taken from Morozov et al. (2012). 
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1.6  A. nidulans as an experimental system  
The ascomycete, A. nidulans is a filamentous fungus which was originally used and 
established as a model genetic system by Pontecorvo et al. (1953). In the late 1960s, John 
Clutterbuck, isolated a strain of A. nidulans that had a mutation he called velvet. The velvet 
allele, veA1, which is recessive, results in colonies with even conidiation, which resulted in it 
being adopted as the standard wild-type strain. Colonies will not overgrow each other, so 
distinct isolates can be grown in close proximity facilitating the use of simple growth tests 
for phenotypic analysis. The organism can grow as either a haploid or a diploid, so 
mutations can be easily isolated in the haploid phase but characterised by cis-
complementation tests. It is homothallic, so theoretically any strain can be crossed to any 
other. Finally, A. nidulans has proven to be a remarkably useful model for higher eukaryotes, 
with many of its genes having close homologues in animal and plant systems (Hu, Qin and 
Liu, 2018). 
 
S. cerevisiae has been used extensively as the model of choice for studies in eukaryotic 
mRNA degradation and translation. However, it lacks cytoplasmic mRNA oligouridylation, 
mRNA splicing is rare and mRNA decay in this organism principally occurs through the 
deadenylation-dependent decapping pathways. In all these respects, A. nidulans represents 
a good alternative. Additionally, due to ease of its manipulation and the wealth of literature 
available including recent observations of mRNA 3’ tagging supports its use. In particular it 
has the potential for providing a fuller understanding of the link between the NMD factors 
and 3’ tagging in mRNA degradation of both normal and aberrant transcripts. 
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1.7  Project aims  
Recent unpublished work in A. nidulans indicates that addition of a short run of pyrimidine 
nucleotides to the 3’ end of histone transcript, mediated by CutA and CutB, is associated the 
response to disruption of DNA synthesis. This response is in part regulated by the NMD 
factors and associated with reduced transcript levels. This is consistent with a model in 
which the addition of a 3’ tag increases the affinity of mRNA molecules for recruitment of 
the Lsm1-7 complex, which, in conjugation with other proteins including Pat1, Dhh1, Scd6, 
Ecd3, Dcp1, Dcp2, Ski3 and Rrp44, stimulates efficient mRNA decay, ribosome recycling and 
translational repression (Morozov et al., 2012). The aim of this thesis was to test this model 
by investigating the role of these different factors in regulating normal and abnormal 
transcripts in order to determine how their roles are linked to the 3’ end tagging.  
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Chapter 2: Materials and Methods 
2.1  Buffers and solutions for general molecular biology  
 Appendix 1a 
 
2.2  A. nidulans strains, oligonucleotides and maintenance  
2.2.1  Oligonucleotides 
All synthetic oligonucleotides used in this project were purchased from Sigma Aldrich UK. 
These are listed in Table 2.1.1.  
 
  Table 2.1.1  Primer sequences used in mutant validation 
Oligonucleotide Primer sequence (5’ – 3’) 
Upf1 F1 ACCGGGAAGTCGTAACGA 
Upf1 F2 CGAGTTGCTTTCCGGTTGCT 
Upf1 F3 CGAGCTTGACGACGCTGAAA 
Upf1 R3 GTGGCTGCAGGCAGATCAGA 
Upf1 R4 TCGGATCATCGTTGCCGTAA 
Upf1 C134S F GAATGCTATAACTCTGGCACCAAGAATGTC 
Upf1 C134S R CTTGGTGCCAGAGTTATAGCATTCTAG 
Upf1 K451Q F CCCGGTACTGGAGAGACAGTCACTTCAGC 
Upf1 K451Q R AAGTGACTGTCTCTCCAGTACCGGGAGGA 
Upf1 RR811AA F CTTGAGTGATCCTGCCGCTCTAAATGTTGCGCTT 
Upf1 RR811AA R CGCAACATTTAGAGCGGCAGGATCACTCAAGAAAC 
Upf1 Fusion F1 CCATGCCATCTTCCAAGGACA 
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Upf1 Fusion F2 GCCCTCTAACGTTGCCGTTG 
Upf1 Fusion R1 CCGGGAGGACCTTGAATCAG 
Upf1 Fusion R2 TTTCTCGCGACCCTGGAAAG 
Upf1 intF1 ACGGAGGCCAGGTTTTAGTT 
Upf1intR1 ACACTCGGGTTCAGCAGACT 
10400 CM1For TGTGCCGTGGCTGAAACGGC 
10400 CM1 Rev GCCGTTTCAGCCACGGCACA 
10400 CM3 For GTTACCAACGCCCGTACTAC 
10400 CM3 Rev TAGTACGGGCGTTGGTAACT 
AN10400_F1 AGGAGGGTGCGAAAGAAGTT 
AN10400_F2 AAATCCTGGACGCCCGATCT 
AN10400_R3 CGGGACGAGTCAGGAGGTGT 
AN10400_R4 ACCAGCGTACCACCCAGATA 
AN10400_IntF GAATGGAGACGAGTCGAAGG 
AN10400_IntR GAAGTCCGCAACTGATGGAT 
ANID 00505 F (8F) ACATAGTCGCCGAGGAACAC 
ANID 00505 R (8R) CCTGAGTTAGGCCTGGAGGT 
Int.Fwd_DCP1 CGATCAACAGAATCGAAGCA 
Int.Rev_DCP1 AAGACCCAAAGCCCGTAAAT 
Dcp2_Int_R AGGATCGTGATTGGTGAAGC 
Dcp2_Int_F AGTGGAACTGTCGGCTCATC 
LSM5 intF AGTCTCGCATTGGAATCGTC 
LSM5 intR AGGAGGATTTTTGGCAGCTT 
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Dhh1 intF TGATGCAAATCCAGATCCAA 
Dhh1 intR GTTTTGCCTGTGCCATTCTT 
RRP44_Int_R1 GCCAAAGAGGAAAGTGTGA 
RRP44_Int_R2 GGCGTCATTTCCCACAGT 
LSM1 intF ACGAGATGGGAGAAAGCTGA 
LSM1 intR GCCGAGCTCTTGTAGCTTGT 
CutB seq For AATGCCGCCAACTCTACATC 
CutB_seq_Rev CGAGCATGTGCAATTGTTTC 
cutA_Int_F0 CACAATACGAAATCTGGGTAATACG 
cutA_int_R2 ACAAGGTTCTGTTGGGCAAG 
Pat1 intF CATCCCTTTATTGCGTTGCT 
Pat1 int R GCGTATGGGTAAGCACCAAGT 
xrn1 Int F2 GTCTCGATGCCGATCTGATT 
xrn1 Int R2 TGGAGGTTTGGCAGATTAGG 
Int_scd6 forward ATTTCCGTTGCCTTCCTTCT 
Int_scd6 reverse CTTGAGGTGGTTGTTGCAGA 
Int_nkuA forward CGCCCAACGACCCTGACG 
Int_nkuA reverse TCCCCGCCGAATTTGTATGC 
Int.Fwd_Af.pyrG ACATCCTCACCGATTTCAGC 
Int.Rev_Af.pyrG TCCCAGCCTTCTTTCTGGTA 
pyrG 3' F CGCATCAGTGCCTCCTCTCAGAC 
cid2_R4 AGGTTAGGGAGGCAGAGAGG  
eRF3 end R4 GCCTCCTCTTACCTCGACCT 
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  Table 2.2.2  A. nidulans strains used in this study   
Genotype Stock Number Source 
Wild-Type (WT): veA+ 1048 This laboratory 
AfpyrG pyroA4 ΔnkuA (pyrG89) 505 This laboratory 
uaZ14 pantoB100 230 This laboratory 
∆upf1 pyroA4 ΔnkuA (pyrG89) 670 This laboratory 
∆upf1 uaZ14 pantoB100 1229 This work 
nmdA1 pantoB100 196 This laboratory 
∆upf3 pyroA4 ΔnkuA 849 This laboratory 
∆upf3 uaZ14 pyroA4 ΔnkuA 988 This work 
∆smg6 pyroA4 ΔnkuA 770 This laboratory 
∆cutA ∆cutB ΔnkuA 1024 This laboratory 
∆lsm1 pyroA4 ΔnkuA 880 This laboratory 
∆lsm5 pyroA4 946 This laboratory 
∆lsm8 hxA5 pantoB100 906 This laboratory 
∆pat1 uaZ14 pantoB100 948 This laboratory 
∆rrp44 pyroA4 ΔnkuA 1033 This laboratory 
∆dhh1 pyroA4 ΔnkuA 779 This laboratory 
∆xrn1 pantoB100 pyroA4 ΔnkuA 973 This laboratory 
∆ski3 974 This laboratory 
∆dcp1 pantoB100 pyroA4 ΔnkuA 972 This laboratory 
∆dcp2 hxA5 pantoB100 pyroA4 yA2 740 This laboratory 
∆dcp2 uaZ14 pantoB100 947 This laboratory 
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∆scd6 uaZ14 pantoB100 pyroA4 969 This laboratory 
∆edc3 uaZ14 pyroA4 ΔnkuA 835 This laboratory 
∆ccr4 pyroA4 pabaB22 riboB2 655 This laboratory 
∆caf1 pyroA4 955 This laboratory 
∆upf1 ∆lsm1 pantoB100 966 This laboratory 
∆upf1 ∆lsm5 1196 This work 
∆upf1 ∆pat1 uaZ14 pantoB100 965 This laboratory 
∆upf1 ∆dhh1 pyroA4 1124 This work 
nmdA1 ∆lsm1 pantoB100 967 This laboratory 
∆cutA ∆cutB ∆lsm1 pyroA4 831 This laboratory 
∆lsm5 ∆lsm8  1142 This work 
∆dcp2 ∆smg6 uaZ14 pantoB100 pyroA4 786 This laboratory 
∆dcp2 ∆rrp44 uaZ14 pyroA4 1031 This work 
upf1C134S pantoB100 1333 This work 
upf1K451Q pyroA4 1334 This work 
upf1RR811AA pyroA4 1354 This work 
upf1C134S uaZ14 pyroA4 1330 This work 
upf1K451Q uaZ14 pyroA4 1331 This work 
upf1RR811AA uaZ14  1332 This work 
smg6D13A D251A 1362 This work 
smg6D13A D251A uaZ14 1363 This work 
∆dcp2 smg6D13A D251A 1359 This work 
∆dcp2 smg6D13A D251A uaZ14 1360 This work 
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cutA ∆ct 728 This laboratory 
CutB:S-tag: AfpyrG pyroA4 ΔnkuA (pyrG89) 1153 This work 
CutA:S-tag:AfpyrGpabaB22 riboB2 ΔnkuA (pyrG89) 1217 This laboratory 
CutA:GFP: AfpyrG pyroA4 1241 This laboratory 
CutB:S-tag CutA:GFP 1298 This work 
∆lsm1 CutB:S-tag: AfpyrG pantoB100 (pyrG89) 1200 This work 
eRF3:S-tag: AfpyrG ΔnkuA (pyrG89) 1156 This work 
∆lsm1 eRF3:S-tag: AfpyrG pantoB100 (pyrG89) 1197 This work 
∆cutA∆cutB eRF3:S-tag: AfpyrG pantoB100 (pyrG89) 1224 This work 
 
2.3  A. nidulans solutions and media  
Appendix 1b 
 
2.4  Maintenance and growth of A. nidulans strains  
A. nidulans stock cultures were kept as conidia using premade glycerol stocks from the 
Protect Microorganism Preservation System (Technical Service Consultant Ltd) at - 80 ˚C. For 
the preparation of conidial suspensions to inoculate liquid cultures, strains were grown on 
minimal media (MM) (Appendix 1b) containing 3% agar (w/v) with appropriate supplements 
for 3-4 days at 37 ˚C. Conidial were scrapped from the plates and resuspended in 10 ml 
0.01% Tween, and grown in 200 ml MM in 1 litre flask. Liquid cultures were incubated at 30 
˚C in an orbital incubator at 180 rpm for 16 hours. Mycelia were harvested by filtration 
through Miracloth (Calbiochem Corp.), washed with cold water, dried by blotting with paper 
towel and frozen in liquid nitrogen.  
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2.5  A. nidulans genetic techniques  
2.5.1  Crosses  
For sexual crosses the procedure is as described by Todd et al. (2007). The parental strains, 
with complimentary auxotrophic and preferably colour markers, were inoculated alternately 
on a fully supplemented agar plate. After 3 days of incubation at 37 ˚C, the junction of 
growth between the two parental strains was transferred to unsupplemented MM agar 
plate with NaNO3 as nitrogen source. The mycelia were inoculated under the surface of a 
thick layer of agar (~50 ml/ dish). The plates were incubated for 14 days or more at 37 ˚C. 
Mature cleistothecia were picked and rolled on a 1% MM plate to clean it from cell debris. 
The cleistothecia were then individually squashed in a vial containing 2 ml of sterile water 
and vortex vigorously. A loop full of ascospore suspension was then inoculated onto 
complete medium (CM) (Appendix 1b) and incubated at 37 ˚C for 2 days. Ascospore 
suspensions that appeared to have the re-assortment of markers were plated out in dilution 
series onto fully supplemented MM. After three days, 23 progenies were randomly picked 
and inoculated onto a master plate, which also containing both parental strains and a wild-
type control. The master plates were incubated at 37 ˚C for three days before replica plating 
onto test media. 
 
2.5.2  Plate tests  
Progeny were grown on differently supplemented media (Minimal media with 1% (w/v) 
agar) to check the growth requirements and morphology. Plates were scored after two days 
of incubation at 37 ˚C.  
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2.6  Generating A. nidulans mutants  
The protocol for transformation in this study was based on the method developed by Dr 
Joan Tilburn (Tilburn et al., 1983), and modification made by Dr Berl R.Oakley (Szewczyk et 
al., 2007). All the glassware was acid washed to remove any traces of detergent which could 
rupture the protoplasts (Magdalena Mos 2010).  
 
2.6.1  Generation of A. nidulans protoplasts 
108 of fresh conidia were inoculated into 25 ml fully supplemented CM and grown overnight 
at 30 °C with agitation at 180 rpm. After 14 hours growth, the culture was harvested using a 
sterile funnel lined with miracloth (Calbiochem). The cells were transferred to a new falcon 
tube containing 8 ml of CM, 8 ml of 2 x protoplasting solution (1.1 M KCl, 0.1 M citric acid pH 
5.8, and 2 g of VinoTaste Pro lysing enzyme (Novozymes). The cells were incubated with 
gentle shaking at 30 °C for 2 hours. Then the protoplasts were filtered through a sterile 
sintered glass funnel containing glass wool and washed with an equal volume of protoplast 
wash solution (1 M sorbitol, 10 mM Tris-HCl, pH 7.5). The mixture was centrifuge at 3,100 g 
(Megafuge 1.0R, Heraeus) for 12 minutes at 4 °C. The supernatant was discarded and the 
pellet re-suspended with 1 ml protoplast wash solution and transferred to a 1.5 ml tube. 
The mixture was centrifuge at 6,500 g for 2 minutes and the washing step was repeated for 
another 2 times. The pellet was re-suspended in 500 µl transformation solution (1 M 
sorbitol, 10 mM CaCl2, 10 mM Tris-HCl, pH 7.5). Protoplasts were counted and diluted to 1 x 
108 for transformation.   
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2.6.2  Transformation of A. nidulans strain  
Up to 50 µl DNA (~60 ng per µl) was added to 150 µl protoplasts and the mixture was 
transferred to a plastic universal containing 50 µl PEG solution (60% Polyethylene glycol 
6000 10 mM CaCl2, 20 mM Tris-HCl, pH 7.5) and incubated on ice for 20 minutes. 1 ml PEG 
solution was added and the mixture was incubated at room temperature for 5 minutes. 
Then, 5 ml transformation solution was added and the mixture was incubated on ice. Then, 
15 ml of regeneration media (MM with 1 M sucrose, 1% glucose) were added into the 
mixture and layered on top of regeneration media plates. Plates were incubated at 30 °C 
overnight and transferred to 37 °C for additional two days until transformants had 
appeared.  
  
2.7  Escherichia coli strains, growth, maintenance and manipulation  
The E. coli strain used in this project was DH5-alphaTM (DH5α) (Thermo).  
  
2.7.1  Escherichia coli growth and maintenance  
E. coli was grown on Luria-Bertani (LB) agar, or in LB liquid media in orbital incubator (200 
rpm), at 37 ˚C for all standard protocols. Long term storage of E.coli strains was achieved 
using a Protect Microorganism Preservation System (Technical Service Consultant Ltd) and 
stored at - 80 ˚C.  
  
2.7.2  Antibiotics and plasmids  
PCR products were cloned into pGEMT-EasyTM (Promega) which has an ampicillin 
resistance gene. For selection and maintainence of plasmids within the E. coli, 50 µg/ml 
ampicillin (amp) was added to the solid or broth media.  
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 2.7.3  Plasmid DNA isolation  
Small scale plasmid preps were performed using the GeneJET Plasmid Miniprep Kit (Thermo 
Scientific) according to the manufacturer’s instructions.   
   
2.7.4  Restriction digests  
Restriction digests of plasmids were performed with standard restriction enzymes (NEB) 
according to the manufacturer’s instructions. Plasmid DNA was normally digested for at 
least 120 minutes at 37 ˚C.  
 
2.7.5  Ligation of DNA fragments  
All DNA fragments were ligated using the T4 DNA Ligase (Promega) according to the 
manufacturer’s instructions. 
 
2.7.6  DNA purification  
DNA fragments from agarose gels were extracted using QIAquick Gel Extraction Kit (Qiagen) 
according to the manufacturer’s instructions.  
 
2.8  Molecular techniques for the manipulation of DNA  
2.8.1  Genomic DNA extraction  
Genomic DNA extraction was carried out from strains grown in SC with 1% (w/v) agar. 
Hyphae and conidia were transferred to a sterile 2.0 ml microcentrifuge tube containing 
glass beads (180 µm) and 1 ml of extraction buffer (100 mM Tris pH 8.0, 1.4 M NaCl, 10 mM 
EDTA, 2% CTAB). The mixture was homogenised using a PowerLyzer® 24 Bench Top Bead-
Based Homogeniser (MO-Bio) at 3,000 rpm for 90 seconds. The suspension was incubated at 
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65 ˚C for 10 minutes before centrifugation for 2 minutes. 700 µl of supernatant was 
transferred to a new 2 ml tube containing 4 µl RNase (100mg/ml) and the tube was 
incubated at 37 ˚C for 30 minutes. An equal volume of phenol: chloroform: Isoamyl alcohol 
(v/v, 25:1) was added. The mixture was vortexed and centrifugated at maximum speed for 2 
minutes. 600 µl of the aqueous phase were transferred to a new 2 ml tube and the 
chloroform extraction was repeated. An equal volume of isopropanol was added to the 
aqueous phase and the mixture was incubated on ice for 5 minutes. Then, the mixture was 
spun at maximum speed for 5 minutes and the pallet was washed twice with 70% ethanol. 
Pellets were air dried on bench for 5 minutes before dissolving it with 150 µl nuclease-free 
water. The genomic DNA was used directly for PCR or stored at - 20 ˚C. 
 
2.8.2  Nucleic acid quantification 
The quantity of DNA and RNA was measured with NanoDrop-1000 (Thermo Scientific) using 
a 1 µl sample per measurement.  
 
2.8.3  Agarose gel electrophoresis of DNA and RNA  
Agarose gel electrophoresis of DNA was performed in Fisher brand horizontal 
electrophoresis gel tanks (Fisher Scientific) using agarose (Bioline) at a concentration 
between 1% to 2% (w/v) in 1X TAE (0.4 M Tris-acetate, 1 mM EDTA) buffer. Gels were run at 
100 V until the bromophenol dye reached ¾ of the gel length. DNA was stained by the 
addition of 2 µl Midori Green (NIPPON Genetics EUROPE) per 100 ml agarose gel for 
visualization under the UV light using the U-Genius (Syngene Imager). Hyperladder 1 or 
Hyperladder 1kb (Bioline) were used as a molecular weight marker.  
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2.8.4  Polymerase Chain Reaction (PCR) from genomic and plasmid DNA  
2.8.4.1  Standard PCR  
PCR analysis was carried out using: 
2X BioMixTM Red (Bioline) 5 µl 
Genomic DNA (0.1 µg) 1 µl 
Forward primer (10 µM) 0.1 µl 
Reverse primer (10 µM) 0.1 µl 
Nuclease-free water 3.8 µl 
 
All the forward and reverse primers used in this experiment are listed in Table 2.1.1 The 
standard PCR program was as follows: 
Pre-denaturation                 95 °C, 3 minutes 
30 cycles Denaturation      95 °C, 30 seconds 
Primers annealing 60 °C, 30 seconds 
Extension 72 °C, 1 minute 
Final Extension                    72 °C, 5 minutes 
 
2.8.4.2  Fusion PCR  
PCR amplification of DNA fragments to be fused together was performed using the Phusion 
High-Fidelity DNA Polymerases (Thermo Scientific). The two PCR fragments to be fused were 
synthesised with an overlapping region of approximately 25 bp by inclusion of this sequence 
at the 5’ ends of the relevant primers. The fragments were amplified individually using two 
different PCR reactions. Where appropriate the oligonucleotides were designed to harbour 
specific mutations. Annealing temperature and extension times varied with primers and 
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product sizes. PCR products of the correct size were gel extracted and then combined as the 
DNA substrates for the second Fusion PCR reaction. The reaction mixture for fusion PCR as 
below: 
2 flanking DNA fragments (~100ng) 1 µl 
DNA-TAG fragment (200ng) 1 µl 
Primer F1 (20 mM) 1.25 µl 
Primer R3 (20 mM) 1.25 µl 
dNTPs (10 mM) 1 µl 
Phusion High-Fidelity DNA Polymerases 1 µl 
Nuclease-free water 43.5 µl 
 
The fusion PCR was performed using the program as follow:  
Pre-denaturation                 98 °C, 30 seconds 
35 cycles Denaturation      98 °C, 10 seconds 
Primers annealing               62 °C, 30 seconds 
Extension 72 °C, 3 minutes 
Final Extension                    72 °C, 5 minutes 
 
2.8.4.3  cRT-PCR and RNA-Seq 
20 μg of total RNA was treated with 25 U of DNase I (Thermo Fisher) and 40 U of RNasin 
(invitrogen) in 50 μl reaction for 30 minutes at 37 °C. The RNA was then purified with equal 
volume of phenol/chloroform and precipitated with ethanol. For decapped transcripts (to 
analyse the decapped mRNAs only), 5 µg of DNA-free RNA was treated by rAPid Alkaline 
Phosphatase (Roche, cat. No 04-898-133-001) for 30 minutes at 37 °C followed by 
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phenol/chlorophorm purification and precipitated with ethanol. The remaining DNase I 
treated RNA (dephosphorylated) was incubated with 2.5 U of TAP (Epicentre 
Biotechnologies) and 20 U of RNasin in 20 μl, containing 1-fold TAP buffer (supplied) for 45 
minutes at 37 °C. RNA was purified as above and resuspended in 16 μl of DEPC-H2O. 
Circularisation of the remaining decapped RNA was performed in 200 μl, containing 10 U of 
T4 RNA ligase 1 (Thermo Fisher, EL0021) and 20 U of RNasin for 16 hours at 16 °C. The 
samples were then extracted and purified with ethanol as above and were suspended in 12 
μl of DEPC-H2O.  
 
Then 5 μl of the RNA was used to perform reverse transcription (cDNA) using SuperscriptII 
(Invitrogen). The cDNA synthesis was performed as followed: RNA was combined with 1.5 μl 
of the mixture 1 (2 volumes of random hexamer primers (10 μM): 1 volume of dNTPs (25 
mM each): 3 volumes H2O) and was incubated for 5 minutes at 65 °C followed by incubation 
on ice for 5 minutes. Then 3 μl of mixture 2 (2 volumes of the 5X First strand buffer: 1 
volume of the 100 mM DTT) was added to the RNA:primer:dNTP solution and incubated for 
2 minutes at room temperature followed by addition of 0.5 μl Reverse Transcriptase and 
incubated for 90 minutes at 42 °C. 1 μl of the cDNA was diluted 10-fold in 25 μl PCR reaction 
using Q5 Hot Start High-Fidelity 2X Master Mix (New England Biolabs) and primers tailed 
with universal sequences to amplify up the joined 5’ and 3’ UTRs. A total of 25 cycles were 
performed followed by the analysis on 2% agarose gel. The resulted products with the 
correct size were purified from the gel and sequenced by Pacific Biosciences, University of 
Liverpool.  
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2.9  Molecular techniques for the manipulation of RNA  
To minimise degradation of RNA by ribonucleases, all the consumables were autoclaved 
twice. Disposable gloves were worn at all times during the preparation of materials and 
solutions used, as well as during the extraction and handling of RNA. To prepare the 
solutions, diethyl pyrocarbonate (DEPC) was added to distilled water and autoclaved.  
 
2.9.1  RNA preparation from A. nidulans - Uric acid treatment 
Strains were grown in 200 ml minimal medium with nitrate as nitrogen source and 
incubated overnight at 30 ˚C with agitation at 180 rpm.  After 16 hours growth 0.1mg/ml 
uric acid was added to the cells for 2 hours prior to harvesting. This step was carried out to 
induce the expression of uaZ gene. Mycelia were harvested and washed with cold water 
twice and pressing it between the paper towels before transfer immediately to liquid 
nitrogen. Then, approximately 0.5 g frozen mycelia were placed in pre-filled VWR® 
Reinforced bead mill tubes containing 600 µl of lysis buffer (100 mM Tris-Cl pH 8.0, 600 mM 
sodium chloride, 10 mM EDTA, 5% sodium dodecyl sulphate, SDS) and 600 µl of phenol. The 
cells were homogenised using a PowerLyzer® 24 Bench Top Bead-Based Homogeniser (MO-
Bio) at 4,000 rpm for 90 seconds. Supernatants were phenol:chloroform (1:1) extracted 
followed by 5 M lithium acetate precipitation. Pellets were then washed with 70% ethanol 
before dissolving in DEPC-water. RNA concentrations of each sample were determined 
spectrophotometrically. 
 
2.9.2  RNA preparation from A. nidulans - Hydroxyurea treatment 
Cells were grown to the logarithmic phase in synthetic complete (SC) medium and incubated 
overnight at 30 ˚C with agitation at 180 rpm. After 16 hours growth hydroxyurea (1.5 mg 
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ml−1) was added to the cultures to inhibit DNA synthesis, 20 minutes prior to the first sample 
being taken. Mycelia were harvested pressing it between the paper towels before transfer 
immediately to liquid nitrogen. Then, approximately 0.5 g frozen mycelia were placed in 
pre-filled VWR® Reinforced bead mill tubes containing 600 µl of lysis buffer (100 mM Tris-Cl 
pH 8.0, 600 mM sodium chloride, 10 mM EDTA, 5% sodium dodecyl sulphate, SDS) and 600 
µl of phenol. The cells were homogenised using a PowerLyzer® 24 Bench Top Bead-Based 
Homogeniser (MO-Bio) at 4,000 rpm for 90 seconds. Supernatants were phenol:chloroform 
(1:1) extracted followed by 5 M lithium acetate precipitation. Pellets were then washed with 
70% ethanol before dissolving in DEPC-water. RNA concentrations of each sample were 
determined spectrophotometrically. 
 
2.9.3  Northern blotting  
2.5 grams of agarose (Bioline) was melted in 206 ml DEPC water. When cooled, 25 ml of 10X 
MOPS (20mM MOPS, 5 mM sodium acetate, 1mM EDTA) and 14 ml formaldehyde were 
added to the agarose solution. This was mixed and poured into the gel mould.  RNA samples 
were prepared by adding 10 µl 2X sample buffer (50 µl formamide, 18 µl 37% formaldehyde 
(~2.2 M), 10 µl 10X MOPS buffer and 3 µl 10X Dye Solution (50% glycerol, 0.3% 
bromophenol blue). Samples were then denatured at 65 ˚C for 15 minutes and immediately 
transferred to ice before loading. The gel was submerged in 1X MOPS and the samples were 
run for 1 hour at 110 V. After electrophoresis, the RNA was transferred from the gel to the 
Zeta Probe GT (BioRad) blotting membrane in 10X SSC (1.5 M NaCl, 0.15 M Na-Citrate, pH 
7.0) overnight. Then, the membrane was rinsed in 2X SSC twice for 10 minutes and air dried. 
RNA was fixed to the blot by vacuum drying for 45 minutes at 80 ˚C. The membrane was 
then hybridised at 65 ˚C to DNA probes radiolabelled with 32P – dCTP. Imaging was 
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conducted using a Molecular Dynamics STORMTM scanner and quantification was done 
using ImageQuant TL Software (GE Healthcare Life Sciences). 
 
2.9.4  Polysomal analysis 
The method was adopted from Morozov et al. (2012) with some modifications. Mycelia 
from overnight cultures were harvested immediately after 10 minutes treatment with 
cycloheximide (0.1 mg ml−1) to trap elongating ribosomes (t0); and where appropriate with 
Hydroxyurea (1.5 mg ml−1) 10 minutes prior to cycloheximide treatment (t20). Harvested 
mycelia were washed with 20 mM Tris-HCl, pH 8.0, 140 mM KCl, 1.5 mM MgCl2 and 0.1 mg 
ml−1 cycloheximide; frozen in liquid nitrogen; and stored at − 80 °C. Approximately 0.5 g 
mycelia was ground in liquid nitrogen with a mortar and pestle, and the powder was 
resuspended in 1 ml ice-cold RNA lysis buffer (20 mM Tris-HCl, pH 8.0, 140 mM KCl, 1.5 mM 
MgCl2, 0.1 mg ml
−1 cycloheximide, 1% Triton X-100, 1 mg ml−1 heparin, 0.5 mM DTT and 1 µl 
RNasin). Cell debris was removed by centrifugation at 4,000 × g for 5 minutes at 4 °C. The 
supernatant was clarified by further centrifugation at 10,000 × g for 5 minutes at 4 °C. 
Aliquot (800 μg) of RNA was layered on 10 ml of 10 to 50% (w/v) sucrose gradient and 
centrifuged at 37,000 rpm at 4 °C for 170 minutes. The gradient was fractionated with the 
BioLogic LP system at a flow speed of 0.8 ml min−1 (Bio-Rad). The gradient was collected at 
0.8 ml/min/tube. 1 ml phenol and 10 µl 10% SDS were added. RNA was precipitated by 
adding 2 volumes of 100% ethanol, 70 µl 3 M sodium acetate (pH 5.0). The RNA was again 
precipitated by addition of 10 µl 3 M sodium acetate (pH 5.0) and 2.5 volumes of 100% 
ethanol. The resulting samples were subjected to Northern analysis. 
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2.10  Molecular techniques for analysing proteins 
2.10.1  Protein isolation 
Approximately 0.5 g mycelia was ground in liquid nitrogen with a mortar and pestle, the 
powder was resuspended in 800 µl lysis buffer (25 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1% 
Trition-X, 1:100 protease inhibitor cocktail (Sigma, P8215). Depending on the experiment, 
RNAse or RNase inhibitor were added to the samples; vortexed and shaken on ice for 10 
minutes. Cell debris was removed by centrifugation at 4,000 × g for 5 minutes at 4 ˚C. 600 µl 
of supernatant was transferred to a new Eppendorf tube. The supernatant was clarified by 
further centrifugation at 10,000 × g for 5 minutes at 4 ˚C. 500 µl of the supernatant was 
transferred to a new Eppendorf tube. Cell lysate was used directly for protein quantification 
and visualisation by Western blot analysis. 
 
2.10.2  Antibodies 
Immunogen affinity purified primary goat polyclonal anti-S tag anti-body (Cat. No. ab19321) 
was obtained from Abcam. GFP (Green Fluorescent Protein) Monoclonal Antibody, Mouse 
(C163) from Thermo Fisher Scientific (Cat. No. 33-2600). Affinity purified secondary anti-
body raised in donkey against goat IgG and conjugated to horseradish peroxidase (HRP): sc-
2056 was obtained from Santa Cruz Biotechnology, INC. 
 
2.10.3  Protein analysis of ribosomal fractions 
800 μg of RNA was layered on 10 ml of 10 to 50% (w/v) sucrose gradient and centrifuged at 
37,000 rpm at 4 °C for 170 minutes. The gradient was fractionated with the BioLogic LP 
system at a flow speed of 0.8 ml min−1 (Bio-Rad). The gradient was collected at 0.8 
ml/min/tube. Sodium lauroyl sarcosinate (NLS) and trichloroacetic acid (TCA) were added to 
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final concentrations of 1% and 20% (v/v), respectively, and the solution was precipitated on 
ice for 15 minutes. Centrifugation was carried out at maximum speed for 15 minutes at 4 °C 
and the supernatant was discarded. 1 ml chilled aceton (100%) was added and left at -20 °C 
overnight. Centrifugation was carried out as described above. Pellets were incubated with 3 
µl of 200 mM NaOH on ice for 5 minutes. The pellets were suspended in 30 µl of 
solubilisation buffer (50 mM Tris-HCl, pH 8.0, 2% (w/v) SDS) with the help of a sonicator 
bath. Centrifugation was carried out at 13000 rpm for 2 minutes to pellet any remaining 
insoluble material and the supernatant frozen at -80°C. 12.5 µl of 3x loading buffer (187.5 
mM Tris-HCl, pH 6.8, 2% (v/v) SDS, 30% (v/v) glycerol, 300 mM DTT, 0.06% (v/v) 
bromophenol blue) was added to the samples then heated for 5 minutes in a 98°C heat 
block. Fractions were separated by SDS-PAGE and analysed by Western blot with indicated 
antibodies. 
 
2.10.4  Western blot analysis  
25 µl of the sample was added to 12.5 µL of 3x SDS Loading buffer (2:1). The sample was 
boiled for 5 minutes at 98 ˚C on a heat block to fully denature the proteins. The boiled 
sample was spun at maximum speed on a table top centrifuge (micro-centrifuge 1k15, 
Sigma) for 1 minute to collect all of the condensation to the sample. The samples were 
separated in 10% acrylamide hand-cast gels (Appendix 1c) in Mini-PROTEAN® Tetra 
electrophoresis system (Bio-Rad Laboratories) and transferred onto nitrocellulose blotting 
membrane (Amersham Protran premium 0.45 µm NC, GE Life Sciences, cat. No. 10600003) 
in Mini Trans-Blot® Cell (Bio-Rad Laboratories). Membrane was blocked with 5% non-fat dry 
milk in Tris-buffered saline containing 1:1000 Tween-20 (TBST) for 1 hour at room 
temperature, incubated with primary antibody (1:5000 dilution) in the same solution 
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overnight. Membrane was washed 3 times with TBST for 30 minutes in total, then incubated 
with horseradish peroxidase (HRP) coupled secondary antibody (1:5000 dilution) for 1 hour 
at room temperature, washed 3 times with TBST for 30 minutes in total. Membrane was 
developed with ECL substrate (Bio-Rad Laboratories), and visualised by ImageQuant LAS 
4000 series (GE healthcare life sciences). 
 
2.10.5  Pull-down assay 
Approximately 0.5 g mycelia was ground in liquid nitrogen with a mortar and pestle, the 
resulting powder was transferred to a 2.2 ml tube containing 700 μl lysis buffer (25 mM Tris-
HCl (1M), pH 8.0, 150 mM NaCl (2M), 0.1% (v/v) Tergitol® (NP-40), 1 mM DTT (100mM), 10 
μl protease inhibitor); vortexed and agitated on ice for 10 minutes. Cell debris was removed 
by centrifugation at 4,000 × g for 5 minutes at 4 ˚C; then 600 µl of supernatant was 
transferred to a new 1.5 ml Eppendorf tube. The supernatant was clarified by further 
centrifugation at 10,000 × g for 5 minutes at 4 ˚C; 500 µl of the supernatant was then 
transferred to a new Eppendorf tube. 500 μL of cell lysate containing 5 μl protease inhibitor 
was pre-cleared by adding 50 μl of protein A/G agarose beads (Pierce™, cat. No. 20421), 
incubated at room temperature for 1 hour. 3 μl of immunoprecipitation antibody was added 
to 40 μL of agarose beads in 500 μl lysis buffer, incubated overnight (O/N) at 4°C. Pre-
cleared cell lysate was transferred to agarose beads bound with the antibody, incubated 
O/N at 4°C. The supernatant incubated O/N (agarose beads: AB: cell lysate) was removed by 
a brief centrifugation. Washed with 500 μL wash buffer (50 mM Tris-HCl (1M), pH 6.8, 150 
mM NaCl (2M), 2 mM EDTA (0.5M), 1 % (v/v) Tergitol® (NP-40), 0.5 % (w/v) sodium 
deoxycholate, 0.1 % (w/v) 10% SDS) and the protein complex was eluted from the beads. 
 
 
 
 
 
43 
2.11  Computational analysis  
2.11.1  Sequence analysis  
PCR Primers and hybridisation probes were designed using Primer3 online tools 
(http://biotools.umassmed.edu/bioapps/primer3_www.cgi). Geneious software was used 
for sequence analysis. T-Coffee program was used for multiple alignments of protein 
sequences using the default parameters (output format: ClustalW, matrix: none, order: 
aligned). Jalview software was used to look at and edit multiple sequence alignments.  
 
2.11.2  Databases  
The Aspergillus genome database (http://www.aspgd.org/) 
National Centre for Biotechnology Information (NCBI) database 
(http://www.ncbi.nlm.nih.gov/)  
Conserved domain database (http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi)  
 
2.11.3  Online tools  
Basic Local Alignment Search Tool (BLAST) (http://www.ncbi.nlm.nih.gov/)  
Protein sequence analysis tools (http://www.expasy.org/) 
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Chapter 3:  The role of NMD factors in uaZ14 mRNA regulation 
Introduction 
In mammals, the cap structure of the pre-mRNAs is recognised by cap-binding complex 
(CBC) (Figure 1.1), which is composed of CBP80 and CBP20 proteins (Choe et al., 2012). It 
was demonstrated that CBP80/20-bound transcripts undergo a pioneer round of translation, 
before CBP80/20 is replaced by eIF4E in the cap of most transcripts in the cytoplasm for a 
steady state translation (Ishigaki et al., 2001). Both CBP80/20 and eIF4E have the ability to 
recruit the small subunit of the ribosome (40S) to initiate translation in the cytoplasm (Choe 
et al., 2012). It is believed that NMD occurs only on CBP80/20-bound transcripts which 
harbour EJCs deposited as a result of splicing (Kim et al., 2009). In human cells, it was found 
that a large proportion of histone transcripts remain bound to CBP80/20, rather than eIF4E, 
unlike poly(A)-containing transcripts (Choe et al., 2012). The human histone transcripts 
contain a stem-loop binding protein (SLBP) that binds to a stem-loop structure at the 3′ end 
instead of poly(A) tail (Choe et al., 2012). A significant portion of CBP80 was detected in 
polysomal fractions (Kim et al., 2009) and was also highly enriched in the nucleus (Garre et 
al., 2012). Similar to CBP80 in mammalian cells, yeast cap-binding protein, Cbc1, was also 
detected in all the polysomal fractions, but was concentrated in the sub-polysomal fractions 
(Garre et al., 2012) while eIF4E was mainly detected in higher polysomal fractions (Garre et 
al., 2012). Therefore, it was suggested that Cbc1-bound mRNAs are less efficiently 
translated than eIF4E-bound transcripts (Garre et al., 2012). 
 
In the filamentous fungus N. crassa, it has been shown that the degradation of mRNA 
through the NMD pathway has at least two branches, one only requires the NMD factors 
and the other requires EJC and CBC factors in addition to NMD factors (Zhang and Sachs, 
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2015). However, in S. cerevisiae, a number of the EJC and NMD components present in 
animal systems are absent, and in fission yeast S. pombe, while EJC components are present, 
a role for them in determining mRNA stability via NMD-related pathways was not 
demonstrated (Zhang and Sachs, 2015). Currently there is no comprehensive understanding 
of the evolutionary significance of EJC, NMD and CBC factors and their contribution to NMD 
mechanisms in fungal systems (Zhang and Sachs, 2015). 
 
The genome of N. crassa contains homologs of the NMD components Upf1, Upf2, and Upf3, 
the core EJC components eIF4A3, MAGO, and Y14, and CBC components CBP20 and CBP80 
(Zhang and Sachs, 2015). Similarly, the A. nidulans homologs for a number of NMD and 
decay factors have been identified and their role in the regulation of PTC-containing 
transcripts have also been demonstrated for two of these, NmdA (Upf2) and Upf1 (Morozov 
et al., 2006; Morozov et al., 2012). In A. nidulans, it has been shown that a number of NMD 
and decay factors fully or partially supress the NMD surveillance complex, however it is still 
unclear how these factors associate with each other. Moreover, it has been shown that 
there is a link between mRNA 3’ tagging and the NMD factors in A. nidulans (Morozov et al., 
2012), but again the significance of this modification by the tagging factors CutA and CutB 
enzymes is unclear. 
 
3.1  The role of Upf3 in uaZ14 mRNA regulation 
Previously it has been demonstrated that disruption of Upf1, Upf2/NmdA and Smg6 lead to 
full suppression of NMD in A. nidulans (Morozov et al., 2012; Morozov and Caddick personal 
communication). Additionally, these three proteins appear to play a major role in the 
regulation of histone mRNA in response to HU treatment. Based on work in other organisms 
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an additional NMD component Upf3 has also been found to be important for NMD-
mediated decay. Within the A. nidulans genome sequence a Upf3 orthologue, AN0505, has 
been identified (Figure 3.1.a). A. nidulans Upf3 genomic sequence is 55% identical to Homo 
sapiens (AAG60690.1) and 56% identical to S. cerevisiae (NP_011586.1) orthologues. 
Similarly, A. nidulans Upf3 amino acid sequence is 28% identical to H. sapiens and 25% 
identical to S. cerevisiae. 
 
 
Figure 3.1.a  Multiple sequence alignment of Upf3 of A. nidulans, H. sapiens and S. cerevisiae. The amino 
acid and nucleotide sequence alignments were performed using T-Coffee program. Identical amino acids 
shaded are highlighted in blue using Jalview software. 
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The upf3 loci was deleted using the deletion cassette provided by the fungal genetics stock 
centre (Caddick, unpublished). Transcript analysis was undertaken to determine if Upf3 was 
required for NMD in A. nidulans, using the structural gene for urate oxidase (uaZ). In order 
to assess the effect of disrupting upf3, the ∆upf3 strain was crossed to introduce the uaZ14 
allele containing an ochre mutation, terminating the 301-residue uaZ protein prematurely 
after residue 131 in exon 2 (Figure 3.1.b) (Morozov et al., 2006). Strain validation was 
conducted by growth tests for the uaZ14 allele (ability to utilise uric acid as sole nitrogen 
source) and the Upf3 deletions was confirmed by PCR. The respective strains were then 
investigated to compare the levels of uaZ+ and uaZ14 mRNA in both upf3
+ and ∆upf3 
backgrounds. The uaZ14 allele is subject to NMD in the wild-type background due to the 
presence of the PTC (Morozov et al., 2006). All strains were grown overnight in MM in the 
presence of nitrate as the sole nitrogen source. Uric acid was added two hours prior to 
harvesting to induce the transcription of uaZ (Morozov et al., 2012). Total RNA was 
extracted from each strain and quantitative Northern blot analysis was used to monitor 
transcript levels (Figure 3.2.f). 
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Figure 3.1.b  uaZ genomic sequence.  uaZ (AN9470)  has three exons (red) interrupted by two introns (black). 
In uaZ14 an ochre mutation (CAA → TAA) in exon 2, highlighted in blue, terminates uaZ protein. Start codon 
(ATG) and stop codon (TAG) are highlighted in green. 
 
Analysis of the PTC-containing transcript, uaZ14, in the wild-type background, revealed a 
dramatic reduction in levels compared to the wild-type uaZ allele. The equivalent 
experiment in the ∆upf1 and ∆upf3 mutant backgrounds show that the level of PTC-
containing transcripts is significantly higher than in the wild-type background. This is 
consistent with increased stability of NMD substrates in these mutant backgrounds. These 
data demonstrate the lack of an NMD response in the absence of Upf1 and Upf3 proteins. 
Furthermore, Upf3 data is consistent with a model in which Upf3, as part of EJC, plays a 
central role to distinguish aberrant PTC-containing transcripts as in mammalian cells 
(Imamachi, 2012). Moreover, the deletion of upf3 in A. nidulans resulted in a relatively 
normal morphology, whereas deletion of upf1 lead to poor growth (Figure 3.3). This is 
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consistent with Upf1 having important cellular functions in A. nidulans other than its role in 
NMD, which is consistent with observations in other systems (Isken and Maquat, 2008). 
 
3.2  Mutational analysis of Upf1 
Upf1 is a nucleocytoplasmic shuttling protein that associates with the EJC and has been 
characterised as an essential component of the NMD machinery (Shi et al., 2015). Upf1 is an 
ATP-dependent RNA helicase which is known to be regulated by phosphorylation, and it 
contains multiple phosphorylation sites, which are mostly evolutionarily conserved (Durand, 
Franks and Lykke-Andersen, 2016). Previous studies in mammalian systems have revealed 
that Upf1 interacts with several NMD factors, such as Upf2, CBP80, Smg1, Smg5-Smg7, 
Smg6, and eRF1-eRF3 (Imamachi, 2012). Upf1 is a substrate for the protein kinase Smg1 only 
when assembled with mRNA during NMD (Durand, Franks and Lykke-Andersen, 2016). Upf1 
phosphorylation by Smg1 protein kinase results in increased affinity for the Smg5-7 complex 
and Smg6 (Durand, Franks and Lykke-Andersen, 2016). Simultaneous binding of the Smg5-7 
complex and Smg6 to phosphorylated Upf1 are required for NMD (Okada-Katsuhata et al., 
2011). It has been shown that the phosphorylation of Upf1 at threonine 28 (T28) is 
important to induce the binding of Smg6 via its 14-3-3-like domain during NMD (Okada-
Katsuhata et al., 2011). Additionally, phosphorylation of Upf1 at Serine 1096 (S1096) by 
Smg1 kinase is important for Smg5-7 binding to dissociate ribosome and release factors 
from Upf1 (Figure 3.2.c) (Rissland and Norbury, 2009, Hu, Li and Li, 2013). Despite the fact 
that Smg5, Smg6 and Smg7 share the same 14-3-3-like domains, there are differing 
phospho-S/T (serine or threonine) binding properties between the Smg5-7 complex and 
Smg6 (Okada-Katsuhata et al., 2011). In vivo analysis showed that Upf1 can be 
phosphorylated at S1078 and S1116; however these are not required for NMD (Okada-
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Katsuhata et al., 2011). It was suggested that these phosphorylation sites are involved with 
other SQ-motif directed kinases such as ATR, ATM and DNA-PKcs, which dictate Upf1 to 
perform its various cellular functions such as histone mRNA decay or the maintenance of 
genome stability (Okada-Katsuhata et al., 2011). Smg1 is missing from the genome of fungi 
therefore an alternative kinase or kinases are assumed to act on Upf1 (Lloyd and Davies, 
2013). The assembly of Upf1 with these downstream factors is required for the formation of 
the translational termination complex (Durand, Franks and Lykke-Andersen, 2016). Upf1 
sequence identities amongst human, plant, fruit fly, nematode, and yeast are between 40-
62%, which is comparable to ribosomal proteins at 59-67% (Imamachi, 2012). Moreover, the 
sequence identity amongst zebrafish, mouse, and human is over 90% (Imamachi, 2012). 
Such a high level of conservation is indicative of the key role which Upf1 plays in biological 
systems. 
 
Previous studies of both yeast and human Upf1 has shown that changing the residue K498 
to A (K498A) led to a strong defect in Upf1 ATP hydrolysis and ATP binding (Cheng et al., 
2006). The mutation K498A resulted in accumulation of Upf1 with higher levels of 
phosphorylation than wild-type Upf1 (Durand, Franks and Lykke-Andersen, 2016). 
Moreover, mutation of arginine at position 865 to alanine (R865A), within the conserved 
motif VI, has also been found to abolish ATP hydrolysis and ATP binding of human Upf1 
(Cheng et al., 2006). In yeast, it has been proposed that the substitution of cysteine 125 with 
serine (equivalent to C186 of human Upf1) within the CH-domain to be involved in Zn3 
binding which could result in loss of NMD (Cooper, 2000). 
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Based on sequence comparisons using mammalian, yeast and A. nidulans Upf1 proteins 
(Figure 3.2.a), point mutations C134S, K451Q (equivalent to K489Q) and RR811AA 
(equivalent to R865A) were engineered into the putative cysteine- histidine-rich region (CH-
domain) and helicase domain (HD) of A. nidulans Upf1 (Figure 3.2.b). 
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Figure 3.2.a  Domain structure of human Upf1 and sequence alignment of the helicase core domain. (A) 
Schematic diagram showing the Helicase domain of human Upf1 composed of two domains (domains 1 and 2). 
Both domains contain a ‘RecA-like' α/β domain designated as 1A and 2A. In addition to subdomain 1A, domain 
1 also contains two insertions, each of which forms a distinct subdomain, denoted as domains 1B and 1C, 
respectively. (B) Amino acid sequence alignment of HD of human and yeast Upf1 showing conserved helicase 
motifs (I, Ia, II, III, IV, V, VI). Mutated residues are marked with “ * ”. Secondary structural elements of Upf1 HD 
are indicated. The coloring scheme for domains as in (A). Figure taken from Cheng et al., (2006). 
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Figure 3.2.b  Sequence alignment of human (Q92900-2) and A. nidulans (AN0646) Upf1. The amino acid 
sequence alignment was performed using T-Coffee. Based on sequence comparisons using human and yeast 
Upf1 proteins (Figure 3.2.a), the equivalent point mutations C134S, K451Q and RR811AA were defined in A. 
nidulans Upf1. The point mutations are marked. A. nidulans Upf1 amino acid sequence is 59% identical to 
human Upf1. 
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In S. cerevisiae, the CH-domain and HD have been shown to be involved in protein-protein 
interactions with Upf2, eRF3 and CBP80 (Figure 3.2.c) (Imamachi, 2012). Based on in vitro 
studies in human cells, Upf1 interacts with CBP80 via its HD to interact with mRNA cap 
structure (Benhabiles, Jia and Lejeune, 2016). According to previous studies in mammalian 
cells it has been shown that there is a direct interaction between CBP80 and Upf1 (Hosoda 
et al., 2005). This interaction promotes the recruitment of Smg1 associated with Smg5-7 and 
Smg6 (Benhabiles, Jia and Lejeune, 2016). Generally, Upf1 is known to interact with eRF1, 
eRF3, and Smg1 to form a complex termed SURF, which subsequently binds to the EJC 
complex and mRNA decay factors (Kim et al., 2017). Upf2 recruits Upf1 to the EJC, via its 
CH-domain which stimulates Upf1 helicase activity (Benhabiles, Jia and Lejeune, 2016). 
Previously in mammalian cells it has been shown that CBP80 is required to promote the 
recruitment of Upf1 to EJC associated Upf2 (Hosoda et al., 2005). However, their exact role 
in this process is still unclear. Therefore, assuming a high level of conservation the C134S, 
K451Q and RR811AA mutations will allow the question of whether these specific 
interactions are required for NMD in A. nidulans to be answered. 
 
 
Figure 3.2.c  The structure of Upf1. The schematic diagram showing the domains of human Upf1 involved in 
binding NMD factors are indicated (Imamachi, 2012). The position of mutations, C134S, K451Q and RR811AA in 
A. nidulans are indicated on human Upf1. 
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Mutant versions of the upf1 coding region, incorporating the three point mutations, were 
produced by fusion PCR. To achieve this, complementary forward and reverse primers for 
the Upf1 gene harbouring the desired nucleotide changes were synthesised. For each 
mutant allele two gene fragments were produced by PCR, each including an overlapping 
region of approximately 25 bp which harboured the desired mutation. Fusion was then 
accomplished using a second round of PCR using the primary PCR products as the DNA 
template (Appendix 2). Due to the size of Upf1, which is approximately 5.5 kbp, mutant 
constructs were assembled in two parts with a 500-700 bp overlapping regions (Figure 
3.2.d) to facilitate integration by a recombination during transformation (Figure 3.2.e). The 
mutant alleles were knocked into the Δupf1:Af-pyrG+ (pyrG89) strain by selecting for 
resistance to 5-fluoroorotic acid (5-FOA). 
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Figure 3.2.d  The schematic diagram of fusion PCR. The diagram showing the position of the primers on the 
Upf1 gene. A combination of primers were used in a multi-step approach to assemble the mutant constructs in 
two parts with 500-700 bp overlapping regions. 
 
 
 
Figure 3.2.e  The schematic diagram of homologous recombination. The diagram showing the homologous 
integration of Upf1 gene to disrupt Af-pyrG gene. Strains that have a functional Af-pyrG gene can grow in the 
absence of uracil but cannot grow in the presence of 5-FOA, because the pyrG product, orotidine 5’-phosphate 
carboxylase, converts 5-FOA into 5-fluorouracil which is toxic. Therefore, transformants in which Af-pyrG
+
 has 
been replaced by the integration of upf1 derived sequences were selected on the basis of 5-FOA resistance. 
 
Putative transformants were screened by PCR to confirm integration of upf1 mutant alleles 
and the point mutations were confirmed by sequencing. Interestingly, they looked 
phenotypically wild-type (Figure 3.3). The resulting upf1 mutant strains upf1 C134S, upf1 K451Q 
and upf1 RR811AA were used to determine if the upf1 mutant alleles disrupt NMD. The 
respective upf1 alleles were crossed into the uaZ14 background and the strains subjected to 
Northern analysis to determine the effect of these mutants on uaZ14 transcript level. Based 
on this analysis it is apparent that both Upf1-K451Q and Upf1-RR811AA disrupt NMD, 
whereas Upf1-C134S had no effect on uaZ14 mRNA stability (Figure 3.2.f). This is consistent 
with previous results of yeast and human Upf1 where both K451Q (Motif I) and RR811AA 
(Motif VI) were strongly defective for ATP hydrolysis and ATP binding (Cheng et al., 2006). 
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Upf1-C134S (C125S In yeast) has been proposed to disrupt NMD (Cooper, 2000). However, 
this mutation has not been tested in humans or yeast (Langley, 2015). These mutants will be 
discussed in more detail in chapter 6. 
 
 
 
 
 
                
Figure 3.2.f  Characterisation of Upf3 and Upf1 mutants with respect to uaZ14 transcript levels. (A) Northern 
blot analysis of total RNA samples was conducted to monitor the level of uaZ
+
 and uaZ14 transcripts in different 
genetic backgrounds: wild-type (WT), ∆upf3, ∆upf1, upf1 C1134S, upf1 K451Q and upf1 RR811AA. The 
phosphorimager data from triplicate experiments were compiled for further analysis. (B) The level of uaZ14 
transcript is presented as a percentage of uaZ
+ 
in the equivalent strain. Bar graph shows calibrated quantitative 
values normalised to 18S rRNA as a control. n = 3 +/- SD. (C) A t-test was done to determine whether there was 
a significant difference between the regulatory response in mutants and in the wild-type strain. A p-value of 
≤0.05 is considered statistically significant (Sig.). 
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3.3  The role of endonucleolytic domain of Smg6 in uaZ14 mRNA regulation 
Phosphorylated Upf1 associates with the phospho-binding proteins Smg5, Smg6, Smg7 and 
general mRNA decay factors, resulting in further rearrangements of this complex which 
leads to mRNA degradation (Hug, Longman and Cáceres, 2016). Smg5 and Smg7 form a 
complex that promotes mRNA deadenylation and decapping. In contrast, Smg6 is an 
endonuclease thought to cleave NMD substrates in the vicinity of the PTC, leading to the 
initiation of NMD-mediated RNA decay (Hug, Longman and Cáceres, 2016, Celik, Kervestin 
and Jacobson, 2015). 
 
Based on preliminary analysis (Morozov and Caddick, unpublished data) it is apparent that 
the putative endonuclease Smg6, is required for NMD in A. nidulans. To determine if this 
specifically involves the endonuclease activity we engineered a double mutant, smg6 D13A 
D251A (Appendix 3) which, based on protein modelling is likely to disrupt the PIN domain 
(Rigden and Caddick, unpublished data). The smg6 mutant allele was inserted into the 
∆smg6:Af-pyrG, pyrG89, pyroA4, ∆nkuA strain as a linear DNA construct, replacing Af-pyrG 
and resulting in resistance to 5-FOA. Putative transformants were screened by PCR to 
confirm reintegration of the smg6 allele. The point mutations were confirmed by 
sequencing. The resulting mutant strain, smg6 D13A D251A, was morphologically similar to wild-
type and ∆smg6 strains (Figure 3.3). 
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Figure 3.3  Growth phenotype of strains harboring mutations in NMD component genes. Photographs of the 
colonies of A. nidulans wild-type (WT) and mutant strains. All strains were grown on solid MM with required 
supplements, for 3 days at 37 ˚C. The deletion of upf1, upf2 (nmdA1) or upf3 resulted in poor growth and 
condition, whereas strains with the upf1 point mutations (upf1 C1134S, upf1 K451Q , upf1 RR811AA),  ∆smg6 
or the smg6- allele with the double substitution (smg6 D13A D251A) disrupting the PIN domain, all showed 
relatively normal morphology. 
 
Based on quantitative Northern analysis of uaZ14 mRNA levels, the catalytic activity of Smg6 
is not required for NMD of the uaZ14 transcript (Figure 3.4). This suggests that the PIN 
domain of Smg6 is either not required or that loss of the putative RNA endonuclease activity 
is masked by RNA degradation mechanism which act in parallel. Moreover, the disruption of 
NMD associated with the ∆smg6 allele, suggests that it has a critical role as part of the NMD 
complex. 
 
3.4  The coordination of decapping and endonuclease cleavage in uaZ14 mRNA regulation 
Based on other systems, mRNA decapping is a key transition point in mRNA degradation, 
facilitating rapid 5’-3’ degradation which is the major degradation mechanism in a wide 
range of organisms, extending from S. cerevisiae to mammalian systems (Kramer, 2017). In 
yeast, mRNA decapping is carried out by a single enzyme composed of Dcp1 and the 
 
 
 
 
60 
catalytic subunit, Dcp2, but also requires the functions of specific regulators commonly 
known as decapping activators (He and Jacobson, 2015). in vivo studies of S. cerevisiae 
indicated that the decapping complex interacted directly with only three decapping 
activators, Edc3, Pat1, and Upf1, and that all three interactions are mediated by Dcp2 (He 
and Jacobson, 2015). Importantly, in S. cerevisiae decapping, mediated by Dcp2, is required 
for NMD (Hu et al., 2010). However, in animal systems endonuclease cleavage by Smg6 can 
either replace decapping, as in D. melanogaster, or be a component of NMD mediated 
transcript degradation, as in human cells (Huntzinger et al., 2008).  
 
Previously it has been shown that disruption of either dcp1 or dcp2 is not sufficient for the 
disruption of NMD targeting PTC-containing transcripts in A. nidulans (Bharudin, 2017). Our 
data shows that the PIN domain is not required in A. nidulans, but this is consistent with 
observations in human cells (Nicholson et al., 2014). To elucidate the role of decapping and 
Smg6 mediated endonucleolytic cleavage in NMD of the uaZ14 transcript, the smg6 
D13A D251A 
was crossed to obtain mutant strains: smg6 D13A D251A, Δdcp2 smg6 D13A D251A, uaZ14 smg6 
D13A 
D251A and uaZ14 Δdcp2 smg6 
D13A D251A. These strains were subject to quantitative Northern 
analysis assay NMD (Figure 3.4). 
 
Based on Northern analysis, neither smg6 D13A D251A or Δdcp2 allele lead to loss of NMD, with 
the levels of uaZ14 mRNA being significantly lower than uaZ
+ in both backgrounds. Strikingly, 
disruption of both decapping, via deletion of Dcp2, and the putative Smg6 endonuclease 
domain, by introducing two amino acid substitutions, led to suppression of NMD. This is 
consistent with NMD acting to stimulate both decapping and mRNA cleavage and in this 
respect is equivalent to the situation observed in mammalian systems (Huntzinger et al., 
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2008). Furthermore, it supports the putative role of A. nidulans Smg6 as an active 
endonuclease. Importantly, deletion of smg6 is sufficient to disrupt NMD (Morozov and 
Caddick, unpublished data), which implies that it forms an essential component within the 
NMD machinery which is distinct from the specific endonuclease function. 
 
 
 
 
Figure 3.4  Characterisation the role of decapping and Smg6 mediated endonucleolytic cleavage in NMD. (A) 
Northern blot analysis of total RNA samples was conducted to monitor the level of uaZ
+
 and uaZ14 transcripts 
in different genetic backgrounds. The phosphorimager data from triplicate experiments were compiled for 
further analysis. (B) Bar graph shows calibrated quantitative values normalised to 18S rRNA as a control (B) The 
average level of uaZ14 expression, relative to uaZ
+
 is indicated as a percentage, for each strain. n = 3 +/- SD. 
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3.5  Summary 
Previously it has been demonstrated that disruption of Upf1, Upf2 and Smg6 lead to full 
suppression of NMD in A. nidulans (Morozov et al., 2012; Morozov and Caddick personal 
communication). Further analysis was undertaken to confirm the previous results and also 
to test an additional NMD factor Upf3 which has been shown to be important for NMD-
mediated decay. Our results clearly demonstrated that Upf1 and Upf3 are required for 
NMD, although the detailed role of the Upf proteins remained to be elucidated in A. 
nidulans. Disruption of Upf1, known as the central component of NMD, lead to reduced 
tagging for wild-type gdhA mRNA and the NMD substrate, uaZ14 mRNA (Morozov et al, 
2012). Therefore, the mutational analysis of Upf1 was undertaken to further characterise its 
role in NMD and its possible link to the tagging factors CutA and CutB will be discussed later 
(Chapter 5). Upf1 mutational analysis data revealed that the Upf1 HD is essential for NMD 
whereas Upf1 CH-domain had no effect on uaZ14 mRNA stability. It is possible that the 
C134S mutation has not disrupted the activity of the CH-domain. However, this mutation 
has not been tested so far (Cooper, 2000). Thus further investigation into whether this 
mutation has an effect on Upf1 interaction with Upf2 is necessary. 
 
In mammalian systems, it has been indicated that simultaneous binding of the Smg5-7 
complex and Smg6 to phosphorylated Upf1 are required for NMD (Okada-Katsuhata et al., 
2011). Based on previous analysis it is apparent that Smg6 is required for NMD in A. 
nidulans. However, its exact role was unclear. Mutational analysis was used to disrupt the 
putative PIN domain. Based on this it was found that the PIN domain of Smg6 was not 
required for NMD. In human cells, it was previously shown that both decapping and Smg6 
mediated endonucleolytic cleavage contribute to NMD mediated transcript degradation 
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(Nicholson et al., 2014). Therefore, further analysis was undertaken to elucidate the role of 
decapping and Smg6 mediated endonucleolytic cleavage in the regulation of uaZ14 
transcript. We observed that although the PIN domain is not required for NMD in A. 
nidulans, this is not the case for a strain which is defective in mRNA decapping. This is 
consistent with observations in human cells where NMD involves both decapping and 
endonuclease cleavage, acting in parallel to degrade the target transcript (Nicholson et al., 
2014). Our results provide compelling evidence that the assembly of an active component 
within the NMD machinery requires Smg6 formation to stimulate both decapping and 
cleavage of transcripts that terminate at the PTC. Since it has been shown that Smg6 cannot 
bind mRNA itself, it is highly plausible that Smg6 is being recruited by phosphorylated Upf1 
to the EJC through Upf2 and Upf3 which, as in human cells, gives further specificity to the 
Smg6 recruitment process (Nicholson et al., 2014). 
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Chapter 4: The role of NMD components in histone mRNA regulation and tagging 
Introduction 
Chromosomes are composed of negatively charged DNA tightly wrapped around small, 
positively charged histone proteins to form a complex termed the nucleosome (T. 
Annunziato, 2008). Nucleosomes consist of two of each H2A, H2B, H3, and H4 histone 
molecules (T. Annunziato, 2008). In human cells, histone mRNA levels are tightly coupled to 
DNA replication. Inhibition of DNA replication, which can be induced using hydroxyurea 
(HU), results in histone mRNA 3’ end oligouridylation which leads to rapid degradation, 
allowing the cell to rapidly adjust the rate of histone protein synthesis (Mullen and Marzluff, 
2008). The NMD factor, Upf1, is known to play a key role in this response to the cell cycle, 
regulating 3’ tagging and degradation of histone mRNA (Mullen and Marzluff, 2008).  
 
In A. nidulans 3’ tagging has been linked to deadenylation dependent mRNA degradation 
and NMD.  Two terminal transferases, CutA and CutB are responsible for this tagging, 
disruption of both resulting in no 3’ tagging being observed (Morozov et al., 2012).  In the 
case of deadenylation dependent mRNA degradation disruption of CutA and CutB leads to 
an increased transcript stability (Morozov et al., 2012) and in the case of NMD decapping, 
which in the wild-type background is poly(A) independent, is predominantly associated with 
deadenylated transcripts (Morozov et al., 2010). Unlike human histone mRNA, in A. nidulans 
the histone transcripts are polyadenylated. However, initial work looking at the H2A 
transcript suggested that a similar response occurs in A. nidulans when DNA synthesis is 
blocked, with the tagging and accelerated degradation of the transcript (Morozov and 
Caddick, unpublished data).  
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In order to confirm these initial observations and characterise both the regulatory system 
and RNA degradation mechanisms involved, we undertook to monitor histone transcript 
regulation including analysing the effect of disrupting several key NMD and mRNA decay 
factors on histone mRNA levels, the regulatory response to the inhibition of DNA synthesis 
and 3’ tagging in A. nidulans. 
 
4.1  Deletion of NMD and decay factors 
The NMD regulatory complex is known to include a number of factors in addition to Upf1 
and Upf2, which prior to this work were the only two characterised in A. nidulans (Morozov 
et al., 2006; Morozov et al., 2013). In order to characterise the role of NMD factors and the 
terminal transferases CutA and CutB, in the regulation of histone transcript, we assessed 
strains deleted for genes encoding Upf1, Upf2, CutA, CutB and two additional NMD factors, 
Upf3 and Smg6. 
 
To investigate the response of histone transcript levels to HU treatment in A. nidulans, 
quantitative Northern blot analysis was used to assay transcript abundance.  For Northern 
analysis, hydroxyurea (1.5 mg ml−1) was added to the cultures to inhibit DNA synthesis for a 
duration of 20 minutes, samples were harvested immediately prior to HU treatment (t0) and 
after 20 minutes in the presence of HU (t20). Total RNA was extracted from the frozen 
mycelia, resolved by agarose gel electrophoresis, transferred to a nylon membrane and 
hybridised with 32P radiolabelled probes for the transcripts encoding H2A (AN3468), H3 
(AN0733) and 18S rRNA as a loading control. 
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Figure 4.1.a  The effect of NMD and decay factors on histone H2A and H3 mRNA regulation in response to 
HU treatment. All strains were treated with HU over a 20 minutes time course (t0-t20), to block DNA synthesis. 
Aliquots (10 μg) of total RNA were resolved on an agarose gel, transferred to a nylon membrane and 
hybridised with a 
32
P radiolabelled probe for H2A and H3 transcripts. Bar graph shows calibrated quantitative 
values normalised to 18S rRNA as a control, giving the relative expression levels as a percentage of the 
untreated samples (t0) for both H2A (Blue) and H3 (red) transcripts after a 20 minutes treatment with HU (t20) 
for the wild-type and mutant strains. n = 3 +/- SD. (B) A t-test was performed to determine whether there was 
a significant difference between the HU response in mutants and in the wild-type strain. A p-value of ≤0.05 is 
 considered statistically significant (Sig.).
 
Assuming that the regulatory response of histone mRNA to HU treatment is mediated 
primarily at the level of mRNA stability, comparing H2A and H3 expression levels in the wild-
type and mutant strains suggests that, disruption of both CutA and CutB, and surprisingly 
Upf3, led to only limited stabilisation of histone mRNA levels. However, disruption of Upf1, 
Upf2 and strikingly, Smg6 resulted in a dramatic effect; where their deletion led to a 
significantly diminished regulatory response for both H2A and H3, compared to the wild-
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type (Figure 4.1.a). These data are consistent with a model in which HU treatment induces 
Upf1 recruitment to the histone transcripts as has been described in human cells (Mullen 
and Marzluff, 2008). However, these data reveal a novel role for Smg6 and Upf2, both of 
which appeared to play a major role in the regulation of histone transcripts in A. nidulans. 
This is different to the situation in human cells, where replication-dependent histone mRNA 
degradation is independent of Upf2 (Kaygun and Marzluff, 2005).  
 
It has been shown that translational termination is linked to mRNA degradation through the 
action of multiple trans-acting factors, including, Pat1, Dhh1 and Scd6, which are known to 
have roles in both processes. Scd6, a decapping activator, is an mRNA binding protein that 
interacts with Dhh1, Dcp2, and Pat1 (Roy and Jacobson, 2013). Pat1 and Scd6 repress 
translation during 48S initiation complex formation and subsequently affect decapping (Roy 
and Jacobson, 2013). It has been shown that direct binding of Scd6 to eIF4G blocked 43S 
complex formation (Roy and Jacobson, 2013). Northern data indicates that the disruption of 
these proteins, particularly Dhh1 and Scd6, has a significant effect on histone mRNA 
stability; deletion of scd6 (AN1055) and dhh1 (AN10417) supressed the regulatory response 
to HU treatment, for both H2A and H3, to a third of that of the wild-type (Figure 4.1.a). 
∆dhh1 displays poor growth phenotype, whereas ∆scd6 showed relatively normal 
morphology (Figure 4.1.b). 
 
 
Figure 4.1.b  Phenotypic effect of mutations disrupting dhh1 and 
scd6. Photographs of the colonies of A. nidulans wild-type (WT) 
compared to the Δdhh1 and Δscd6 strains. All strains were grown 
on solid MM with required supplement for 3 days at 37 ˚C. 
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Disruption of lsm1 (AN6199) and lsm5 (AN5679) reduced the HU regulatory response, 
consistent with partial loss of the histone mRNA degradation response (Figure 4.1.a). These 
data are consistent with a model in which HU treatment induces cytoplasmic Lsm1-7 
complex recruitment to the histone transcripts, which then triggers mRNA degradation, as 
demonstrated in human cells (Mullen and Marzluff, 2008). Moreover, Lsm8 (AN1119) is a 
subunit of another Lsm heptameric complex termed Lsm2-8, which has Lsm8 in place of 
Lsm1 (Zhou et al., 2014). However, in S. cerevisiae the Lsm1-7 complex is cytoplasmic, 
whereas Lsm2-8 complex is localised specifically in the nucleus (Weichenrieder, 2014). 
Assuming conservation of the intracellular localisation of these complexes it is surprising 
that disruption of Lsm8 also suppressed the regulatory response (Figure 4.1.a). It may be 
that in A. nidulans Lsm8 is not exclusively active in the nucleus or alternatively that its 
disruption impacts on the expression and/or distribution of the other Lsm components and 
has an indirect effect on HU induced histone mRNA depletion. 
 
Other components of the 5’-3’ mRNA decay machinery were also investigated. Dcp1, Dcp2, 
Edc3 and Xrn1 are important in mRNA decapping and 5’-3’ degradation. However, their 
disruption only partially inhibited HU induced histone mRNA regulation. Decapping 
enzymes, Dcp1 and Dcp2 had more impact than Edc3 and Xrn1 (Figure 4.1.a). These findings 
suggest that other decay pathway(s), in addition to 5’-3’ decay play a significant role in 
histone mRNA degradation. Again this is consistent with the mammalian system, where 
both 5’-3’ and 3’-5’ degradation are implicated in the regulated degradation of histone 
encoding transcripts (Mullen and Marzluff, 2008). 
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The exosome is a large protein complex responsible for 3’-5’ RNA degradation. Disruption of 
Rrp44, a core exosome component with nuclease activity, partially reduced the HU 
regulatory response, the effect being similar to that seen in the disruption of 5’-3’ 
exonuclease, Xrn1. However, disruption of Ski3 (AN3014) had no effect which suggests that 
this protein is not involved in HU induced mRNA degradation pathway (Figure 4.1.a). This is 
consistent with the role of Ski3 in degradation of non-stop decay substrates (Krebs, 
Goldstein and Kilpatrick, 2017). Disruption of the exonucleolytic activity of the two catalytic 
components of the deadenylase complex, Ccr4 and Caf1 (Morozov et al., 2010), also 
partially supressed the HU response, consistent with partial stabilisation of the histone 
transcripts (Figure 4.1.a). The above data suggest that deadenylation and 3’-5’ degradation 
of mRNA both play a role in histone transcript degradation but are not solely responsible.  
 
4.2  Analysis of genetic interactions by disrupting both NMD and decay factors 
The analysis of strains bearing single mutants disrupting distinct components of mRNA 
degradation mechanisms, suggests that multiple pathways are implicated in the HU induced 
histone mRNA degradation. To investigate this further we undertook to construct a range of 
double mutants.  If the double mutant displays a phenotype which is additive, ie has a more 
extreme phenotype than either single mutant, the implication is that the pathways involved 
are distinct and independent.  If the double mutant’s phenotype is equivalent to the single 
mutants, the implication is that the two mutations are disrupting the same pathway. 
 
A range of double mutants were constructed by crossing appropriate strains bearing single 
mutations in NMD and decay factors. However, some of the double mutants, nmdA1 Δdhh1, 
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Δdcp2 Δdhh1, Δlsm1 Δlsm8, Δlsm1 Δpat1 and Δlsm3 Δlsm5, were not obtained either due to 
the respective crosses being inviable or synthetic lethality.  
 
 
Figure 4.2.a  The effect of double mutants on histone H2A and H3 mRNA regulation in response to HU 
treatment. All strains were treated with HU over a 20 minutes time course (t0-t20), to block DNA synthesis. 
Aliquots (10 μg) of total RNA were resolved on an agarose gel, transferred to a nylon membrane and 
hybridised with a 
32
P radiolabelled probe for H2A and H3. Bar graph shows calibrated quantitative values 
normalised to 18S rRNA as a control, giving the relative expression levels of both H2A and H3 transcripts after 
a 20 minutes treatment with HU (t20) compared to untreated samples (t0) in wild-type and mutant strains. n = 
3 +/- SD. (B) A t-test was performed to determine whether there was a significant difference between the HU 
response in mutants and in the wild-type strain.  A p-value of ≤0.05 is considered statistically significant (Sig.).
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Figure 4.2.b  Growth phenotype of selected double mutants affecting NMD and RNA degradation factors. 
Photographs of the colonies of A. nidulans wild-type (WT) compared to the single and double mutants as 
indicated. All strains were grown on solid MM with required supplement for 3 days at 37 ˚C. 
 
The double mutants, ∆upf1 ∆dhh1, ∆upf1 ∆lsm1, ∆upf1 ∆pat1, ∆upf1 ∆lsm5 and nmdA1 
∆lsm1 all appeared to fully disrupt the HU induced regulatory response for both H2A and H3 
encoding transcripts (Figure 4.2.a). Based on this, these double mutants display additivity, 
consistent with loss of histone mRNA degradation. In contrast the double mutants, ∆lsm5 
∆lsm8, ∆smg6 ∆dcp2 and the treble mutant ∆cutA ∆cutB ∆lsm1, displayed no additivity 
(Figure 4.2.a). One interpretation is that the loss of the HU response implies that at least 
two distinct mechanisms are involved in HU induced mRNA degradation: the NMD complex 
mediating one and the Lsm1-7 activated decapping pathway another. Interestingly, in ∆dcp2 
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∆rrp44 the regulatory response is not diminished, being similar or even closer to wild-type 
than that of the ∆rrp44 single mutant. 
 
4.3  Functional analysis of Upf1 in histone mRNA regulation 
Previously we undertook a more detailed analysis of the role for specific residues within 
Upf1 with respect to NMD. This was done by constructing strains bearing three different 
Upf1 alleles: C134S, K451Q and RR811AA (Figure 3.2.f). We decided to test the effect of 
these mutations on histone mRNA regulation to see if the same domains have a critical role 
or if NMD and HU induced repression of histone mRNA or if the two processes are 
mechanistically distinct. 
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                           B                                                                   C 
                              
Figure 4.3  The effect of Upf1 mutants on histone H2A and H3 mRNA regulation in response to HU 
treatment. All strains were treated with HU over a 20 minutes time course (t0-t20), to block DNA synthesis. 
Aliquots (10 μg) of total RNA were resolved on an agarose gel, transferred to a nylon membrane and 
hybridised with a 
32
P radiolabelled probe for H2A and H3. (A) Bar graph shows calibrated quantitative values 
normalised to 18S rRNA as a control, giving the relative expression levels of both H2A and H3 transcripts after 
a 20 minutes treatment with HU (t20) compared to untreated samples (t0) in wild-type and mutant strains. n = 
3 +/- SD. (B) A t-test was performed to determine whether there was a significant difference between the HU 
response in mutants and in the wild-type strain. (C) An additional t-test was conducted to determine if there is 
a significant difference in response between Upf1 mutants and ∆upf1. A p-value of ≤0.05 is considered 
 statistically significant (Sig.).
 
Quantitative Northern analysis was again utilised to monitor the HU regulatory response for 
H2A and H3 transcripts. In addition to the wild-type and the ∆upf1 mutant strain, three 
strains expressing mutant version of Upf1 were tested. Based on these data amino acid 
substitutions; C134S, K451 and RR810-811AA, all led to partial loss of HU induced repression 
of the histone transcripts (Figure 4.3). This is consistent with the human system, where 
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replication-dependent histone mRNA degradation is mainly dependent of Upf1 (Mullen and 
Marzluff, 2008). Interestingly, all three mutants, upf1 C134S, upf1 K451Q and upf1 RR810-
811AA were shown to have an effect on histone mRNA regulation. This contrasts to the 
effect of these mutations on NMD, where upf1 K451Q and upf1 RR810-811AA, disrupted the 
degradation response but upf1 C134S did not have an effect (Figure 3.2.f). This implies that 
the underlying molecular mechanisms associated with NMD and histone mRNA regulation 
are distinct. 
 
4.4  The role of endonucleolytic domain of Smg6 in histone mRNA regulation 
Previously, we have shown that mutations disrupting the endonuclease PIN domain of Smg6 
lead to loss of NMD in a Δdcp2 background (Figure 3.4). Further analysis was undertaken to 
determine whether fidelity of the PIN domain is similarly required for regulating histone 
transcripts. Based on quantitative Northern analysis of histone mRNA levels in smg6 D13A 
D251A strain, the result suggests that the catalytic activity of Smg6 is not required for the 
regulation of both H2A and H3 transcripts (Figure 4.5). These results are similar to those 
seen for NMD of the uaZ14 transcripts. This suggests that the PIN domain of Smg6, which is 
likely to be required for its putative endonuclease function, is not required for the regulated 
degradation of histone transcripts.  However, the disruption of regulation associated with 
the ∆smg6 allele, suggests that its role as part of the NMD complex is critical. 
 
4.5  The role of Dcp2 and Smg6 in histone mRNA regulation 
Our data indicates that the regulation of histone transcripts can potentially be initiated by 
deadenylation, decapping and/or endonuclease cleavage. This could then be followed by 5'-
3' degradation by Xrn1, and/or 3'-5' degradation by the exosome. Functional analysis of 
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Upf1 uncovered the multiple roles of this factor in the regulation of normal and aberrant 
transcripts. It is possible that Upf1 has functions in mRNA regulation that act upstream of 
the formation of a decapping complex and/or activation of endonucleolytic domain of 
Smg6. We showed with respect to NMD of uaZ14 mRNA, Smg6 forms an essential 
component within the NMD machinery which is distinct from the specific endonuclease 
function. The role of the Smg6 endonuclease activity was only observed in the Δdcp2 
background, where decapping is blocked. Therefore, to check whether the HU histone 
response similarly required the Smg6 PIN domain functionality in the absence of decapping 
the Δdcp2 smg6 D13A D251A mutant strain was tested alongside the Δdcp2 and smg6 D13A D251A 
single mutants. Northern hybridisation analysis demonstrates that the smg6 catalytic 
mutation, smg6 D13A D251A, was not additive with Δdpc2, which as with previous data shows 
only partial disruption of the HU induced regulatory response (Figure 4.1.a). This suggests 
that the mechanisms underlying NMD and histone mRNA regulation are distinct, consistent 
with the Upf1 mutational analysis. Furthermore, although Smg6 is implicated in the HU 
induced repression of histone encoding transcripts, there is no evidence to suggest this 
involves the Smg6 endonuclease activity. More likely is that it is critical as part of the NMD 
complex involving Upf1, Upf2, Upf3 and Smg6, and deletion of Smg6 disrupts this complex. 
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Figure 4.5  Characterisation of decapping and Smg6 mediated endonucleolytic cleavage in histone H2A and 
H3 mRNA regulation in response to HU treatment. All strains were treated with HU over a 20 minutes time 
course (t0-t20), to block DNA synthesis. Aliquots (10 μg) of total RNA were resolved on an agarose gel, 
transferred to a nylon membrane and hybridised with a 
32
P radiolabelled probe for H2A and H3. Bar graph 
shows calibrated quantitative values normalised to 18S rRNA as a control, giving the relative expression levels 
of both H2A and H3 transcripts after a 20 minutes treatment with HU (t20) compared to untreated samples (t0) 
in wild-type and mutant strains. n = 3 +/- SD. (B) A t-test was performed to determine whether there was a 
significant difference between the HU response in mutants and in the wild-type strain. (C) An additional t-test 
was conducted to determine if there is a significant difference in response between Δdcp2 smg6 
D13A D251A
 and 
the single mutants.  A p-value of ≤0.05 is considered statistically significant (Sig.).
 
4.6  The effect of RNA degradation mutants on basal transcript levels 
As transcript levels are a product of both the rate of synthesis and degradation, the 
observation that various mutants affect histone mRNA degradation suggests that they may 
also dramatically altered histone mRNA levels. However, from other systems it is known 
that disruption of many components involved in mRNA turnover do not have a dramatic 
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effect on mRNA levels, implying that there is a compensation mechanism (Houseley and 
Tollervey, 2009). To determine if aberrant histone mRNA levels are associated with the 
mutant tested we undertook comparative Northern analysis. In order to determine if any 
differences were specific to histone mRNA or is shared with other transcripts we 
investigated the gdhA (AN4376) mRNA levels as a comparator. 
 
 
Figure 4.6  The abundance of H2A, H3 and gdhA basal mRNA in wild-type (WT) and mutant strains. The 
strains were grown overnight for 16 hours. Total RNA was extracted from each strain and aliquots (10 μg) of 
RNA were resolved on an agarose gel, transferred to a nylon membrane and hybridised with a 
32
P radiolabelled 
probe for H2A, H3 and gdhA. Bar graph shows calibrated quantitative values normalised to 18S rRNA as a 
control. H2A, H3 and gdhA at t0 transcript levels in mutant strains are given as a percentage of the wild-type 
level before treatment (t0). n = 1. 
 
We detected that the disruption of CutA, CutB, Pat1 and Lsm proteins individually or in pairs 
increased the abundance of basal mRNA levels for H2A and H3 mRNA. This dramatic shift 
was not generally shared with gdhA, although for the Δlsm1, Δpat1 single mutants and the 
treble mutant ΔcutA ΔcutB Δlsm1, there was an increase relative to wild-type (Figure 4.6). In 
the case of Δdcp2, Δdhh1 and the Δdcp2 Δrrp44 double mutant, there was a similarly high 
level of all three transcripts (Figure 4.6). Interestingly, the disruption of Lsm proteins 
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combined with the disruption of Upf2 and particularly Upf1 significantly reduced mRNA 
abundance (Figure 4.6). Interpretation of these data is difficult other than to observe that 
there is not a simple relationship between transcript degradation and abundance and that 
different transcripts are affected in different ways. 
 
4.7  Phenotype analysis of the wild-type and mutant strains 
The importance of NMD effectors in cell viability and organism development varies across 
species (Vicente-Crespo and Palacios, 2010). The work in S. cerevisiae indicated, the loss of 
the Upf proteins has no obvious effect on growth, although PTC-containing mRNAs are 
stabilised in Upf mutants. It was suggested that the fact that the Upf proteins are not 
essential in yeast is because the regulation of targets by NMD in this organism is not 
required for growth (Vicente-Crespo and Palacios, 2010). Similar to the S. cerevisiae, 
deletion of upf2 in S. pombe results in strains which are viable and show no apparent 
growth abnormality, whereas deletion of upf1 produces abnormally long cells probably due 
to problems with cell cycle progression (Vicente-Crespo and Palacios, 2010). upf1 and upf2 
knockout mice show early embryonic lethality (Vicente-Crespo and Palacios, 2010). Mutants 
for A. thaliana upf1 are lethal and show metabolic, flowering, seeding and growth problems 
(Vicente-Crespo and Palacios, 2010). It was not clear whether this phenotype is due to lack 
of NMD or to some other function of the protein (Vicente-Crespo and Palacios, 2010). 
 
The deletion of Upf1 in A. nidulans displays an unhealthy phenotype with reduced colonies 
size (growth rate) and very poor conidiation, whereas upf1 point mutations which disrupt 
NMD and/or histone mRNA regulation showed relatively normal morphology (Figure 3.3). 
We showed the Upf1 point mutations have similar or stronger effect for both H2A and H3 
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mRNAs as compared with that observed with ∆upf1 (Figure 4.3). The abundance of H2A and 
H3 basal mRNAs of ∆upf1, upf1 C134S, upf1 K451Q and upf1 RR811AA are similar to that observed 
with the wild-type. This implies that the dramatic phenotypic effect of the Upf1 deletion 
might be due to its multiple roles including cellular functions other than NMD. Upf1 has 
roles which are important for the cell development, such as in DNA replication, telomere 
metabolism and genome maintenance pathways (Nicholson et al., 2014). Based on our 
observations and data obtained, it is clear that the role of Upf1 in other cellular processes is 
independent of its function in NMD.  
 
Interestingly we observed that the double mutant, ∆upf1 ∆dhh1, displayed a healthier 
phenotype than the ∆upf1 single mutant (Figure 4.2.b); the implication is that the disruption 
of dhh1 partially supresses the effect of upf1 deletion. Interestingly, both Dhh1 and Upf1 are 
RNA helicases. One possibility is that in the absence of Upf1, Dhh1 can bind RNA that is 
normally associated with Upf1 and that this has a toxic effect which contributes to the poor 
Upf1 mutant phenotype. This would fit with the upf1 point mutations and the disruption of 
other NMD components not leading to the extreme mutant phenotype exhibited by ∆upf1 
strains. 
 
The double mutants, ∆upf1 ∆lsm1, ∆upf1 ∆lsm5, ∆upf1 ∆pat1 and nmdA1 ∆lsm1 display an 
extremely poor growth phenotype in addition to loss of HU regulatory response for histone 
transcripts. Based on our observations and data, simultaneous disruption of both NMD and 
certain decay factors dramatically affect the cell viability and development. In previous 
studies, it has been shown that some of these factors are multifunctional, with roles ranging 
from transcription to mRNA decay, implicating them in a feedback loop affecting gene 
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transcription (Maekawa et al., 2015, Haimovich et al., 2013). Therefore, disruption of these 
factors may influence the expression of the genes responsible for cell development. One 
important possibility is that these NMD factors are also involved in general mRNA 
degradation (Morozov et al., 2012) and that the disruption of the two parallel mechanisms, 
NMD and decapping, is leading to this very poor growth phenotype. 
 
4.8  The role of NMD factors in histone mRNA 3’ tagging 
Previously, it was demonstrated that disruption of both the ribonucleotidyltransferases, 
CutA and CutB led to loss of mRNA 3′ tagging in A. nidulans (Morozov et al, 2012). However, 
disruption of both CutA and CutB did not have a major effect on the HU induced repression 
of histone transcripts, whereas disruption of Upf1, Upf2 and strikingly, Smg6 resulted in a 
partial suppression of this response (Figure 4.1.a). Initial data indicated that HU treatment 
induced uridylation of H2A mRNA and that this was dependent on CutA and CutB, and 
regulated by Upf1 (Morozov and Caddick, unpublished data). To investigate the possible role 
of NMD components in histone mRNA 3′ tagging, DNase I treated total RNA was digested by 
alkaline phosphatase to remove 5′-phosphate group from the mRNA cap structure. 
Dephosphorylated mRNA was treated with tobacco acid pyrophosphatase (TAP) to remove 
the 5′ cap structure, exposing a mono-phosphate group for subsequent ligation. The 
resulting decapped 5’-phosphorylated terminus and 3’-hydroxylated terminus were ligated 
using T4 RNA Ligase. The distribution of 5’ and 3’ ends of decapped histone transcripts in 
the respective mutant strains was assessed by circularised reverse transcriptase PCR (cRT-
PCR) followed by sequencing. 
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Figure 4.8  cRT-PCR analysis of histone mRNA. The strains were grown overnight for 16 hours. HU was added 
to the cultures, 20 minutes prior to sampling (t20). Total RNA was extracted from each strain. The RNA samples 
were treated with alkaline phosphatase prior to decapping with tobacco acid pyrophosphatase. Sequences 
were obtained by cRT-PCR using a primer complementary to H2A transcripts. Between 31 and 100 transcripts 
were analysed from each strain. Sequence data analyses indicated the number of tagged transcripts (A), 
tagged full length transcripts + poly(A) tail (B) and the distribution of U, C, A and G nucleotides associated with 
mRNA 3’ tagging in the wild-type and mutant strains (C). 
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From these data, it is clear that a high frequency of mRNA 3′ tagging is induced by HU 
treatment in the wild-type strain (Figure 4.8 A and B). This is consistent with previous 
studies (Morozov and Caddick, unpublished data) and the situation in human cells (Mullen 
and Marzluff, 2008). These data indicated that the deletion of Upf1 leads to retardation of 
H2A mRNA 3’ tagging (Figure 4.8 A and B). This is consistent with published data where 
Δupf1 lead to reduced tagging for wild-type gdhA mRNA and the NMD substrate, uaZ14 
mRNA (Morozov et al, 2012). Interestingly, the Upf1 point mutations did not have an effect 
on tagging (Figure 4.8 A and B), whereas the upf1 mutant strains upf1 C134S, upf1 K451Q and 
upf1 RR811AA had a similar or more extreme effect than the deletion of Upf1 with respect to 
the regulatory response of histone transcripts to HU treatment (Figure 4.3). 
 
Additionally, the frequency of tagging of the capped transcripts is not diminished, relative to 
wild-type, in the nmdA1 and Δupf3 strains unlike the Δupf1 strain (Figure 4.8 A and B). These 
data suggest that Upf1 plays a role in mediating HU induced histone mRNA tagging, which is 
distinct from its role as part of the NMD complex and mRNA degradation in A. nidulans. This 
is consistent with the minor impact that deletion of both cutA and cutB have no HU induced 
repression of H2A and H3 mRNA. However, this opens the question as to the primary role of 
tagging, if it is not to trigger transcript degradation. 
 
CutA has a long C-terminal unstructured domain. Such domains are commonly associated 
with protein-protein interactions and modulation of activity (He and Jacobson, 2015).  
Preliminary work had indicated that a mutation, cutA-ΔCT, leading to C-terminal truncation 
(residues 578 to 1000) results in a high frequency of tagging for the gdhA mRNA consistent 
with deregulation and possible constitutive activation. It is possible that the C-terminal 
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domain of CutA contains the regulatory elements for its activity. Our data supports this with 
high levels of tagging being observed for H2A mRNA independently of HU treatment (Figure 
4.8 A and B). 
 
The distribution of nucleotides associated with mRNA 3’ tagging are displayed in Figure 4.8 
C. These data are consistent with other systems where U > C > A > G (Chang et al., 2014). 
This distribution is similar before and after treatment with HU in the wild-type strain. 
However, disruption of Upf1 resulted in an altered distribution with a high frequency of 
tagging with G and a very low frequency of A tags compared to the wild-type strain (Figure 
4.8 C). Interestingly, the Upf1 point mutations did not appear to alter tagging composition 
(Figure 4.8 C). This is consistent with these mutations not impacting on the regulation of 
tagging, unlike Δupf1 (Figure 4.8 A and B). in vitro analysis of CutA showed that ATP, UTP 
and CTP are all substrates (Kobyłecki et al., 2017). CutA is processive for ATP, leading to 
polyadenylation but only short tracts of C or U, consistent with short tags normally observed 
and terminating in C or U nucleotides (Kobyłecki et al., 2017). 
 
Previously, it was demonstrated that disruption of both CutA and CutB led to loss of mRNA 
3′ tagging in A. nidulans (Morozov et al., 2012). Disruption of Upf1 leads to significant 
retardation of mRNA 3’ tagging compared to other NMD factors. Based on these findings it 
is likely that, in the absence of Upf1, both CutA and CutB are still being recruited to the 
histone transcripts but in the wild-type, Upf1 stimulates their recruitment or activity during 
HU induced degradation. This is consistent with the human system where Upf1 is implicated 
in recruiting the decay factors (Mullen and Marzluff, 2008). 
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4.9  Summary 
Our previous results (Chapter 3) clearly demonstrated that the assembly of the active NMD 
machinery requires Upf1, Upf2, Upf3 and Smg6 to stimulate both decapping and cleavage of 
transcripts that terminate at a PTC. Based on other systems it is highly plausible that 
phosphorylated Upf1 facilitates Smg6 recruitment to the EJC through Upf2 and Upf3 
(Nicholson et al., 2014). However, we found that the disruption of the catalytic PIN domain 
of Smg6 was not required where the decapping complex, Dcp1-Dcp2 was present.  
Importantly, in the absence of this active complex the endonuclease domain of Smg6 is 
required. This shows that both means of cleaving the NMD substrate, ie decapping and 
endonuclease cleavage, are utilised in A. nidulans, as in mammalian systems (Huntzinger et 
al., 2008). 
 
Our data demonstrate that the NMD components, Upf1, Upf2 and Smg6, all play a major 
role in histone mRNA regulation but this is mechanistically distinct from NMD. With respect 
to smg6, HU induced regulatory response of histone coding mRNA is not dependent on 
fidelity of the PIN domain in the Δdcp2 background. Based on this distinction between NMD 
and histone mRNA regulation we conclude that the histone transcripts are unlikely to be 
cleaved by Smg6, but this protein probably plays a critical role as part of a protein complex 
involving other NMD components, which is also important for NMD itself. 
 
Additionally, our results clearly indicated that Upf3 is required for NMD but not essential for 
histone transcripts regulation. Finally, Upf1 mutational analysis demonstrated that specific 
residues in both the HD and CH-domain are essential for histone regulation, whereas those 
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in the Upf1 HD disrupted NMD, consistent with a fundamental difference between the two 
processes. 
 
Disruption of both CutA and CutB, did not have a major effect on the HU induced repression 
of histone transcripts. This is consistent with the pervious results where the uaZ14 transcript 
was not stabilised by disruption of either gene (Morozov et al., 2012). However, our data 
indicates that the deletion of upf1 leads to reduced histone mRNA tagging. This is consistent 
with published data where Δupf1 led to reduced tagging for wild-type gdhA mRNA and the 
NMD substrate, uaZ14 mRNA (Morozov et al, 2012).  Interestingly, the Upf1 point mutations 
that affected NMD and/or histone mRNA regulation, did not have an effect on tagging. 
Regarding these observations, what remains unclear is the primary function of mRNA 3’ 
tagging; as it appeared that the absence of tagging had no major impact on the regulation of 
both uaZ14 and histone transcripts. 
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Chapter 5: Characterising the role of 3’ tagging 
Introduction 
In A. nidulans, the 3’ tagging of mRNA involves the catalytic activity of a CutA and CutB. Our 
data indicated that HU treatment increases 3’ tagging of histone transcripts. This is 
consistent with 3’ tagging playing a role in the regulation of histone mRNAs in A. nidulans, as 
has been observed in human cells (Mullen and Marzluff, 2008). In human cells, it was 
demonstrated that histone mRNAs with oligouridylated 3′ ends are likely to recruit the 
Lsm1-7 complex (Mullen and Marzluff, 2008), which is a known activator of decapping and 
translational repression (Wu et al., 2013). Our data indicated that disruption of a number of 
factors involved in decapping, including Lsm1 and the decapping enzyme Dcp2, reduced 
histone mRNA degradation induced by HU treatment. This implies that activation of 
decapping plays a direct role in the HU induced regulation of histone mRNA abundance and 
that CutA and CutB mediated 3’ tagging is an integral component, helping to trigger this 
regulatory mechanism. Furthermore, ∆lsm1 ∆cutA ∆cutB treble mutant’s phenotype is 
equivalent to the single mutants with respect to histone mRNA regulation (Figure 4.2.a); this 
implies that Lsm1, CutA and CutB mutations are disrupting the same pathway. 
 
Based on analysis of the effect of mutations disrupting cutA or cutB, it appears that defects 
in 3’ tagging result transcripts subject to NMD accumulating in ribosomal fractions (Morozov 
et al., 2012). This suggests that 3’ tagging occurs prior to dissociation of transcripts from 
ribosomes and that it has a role in translational repression and/or the dissociation of 
ribosomes from the transcript after termination. In A. nidulans 3’ tagging has also been 
linked to deadenylation dependent mRNA degradation. This transition, which correlates 
with mRNA decapping, occurs when the poly(A) tail reaches a threshold length of A15 and in 
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A. nidulans this is also the point at which 3’ tagging occurs (Morozov et al., 2012). This is 
consistent with tagging being closely linked to the point of transition for translation of a 
functional transcript to translational repression and degradation. All these pieces of 
evidence indicate that CutA and CutB may be associated with the ribosomes. Furthermore, 
confocal microscopy analysis was undertaken to locate fluorescently tagged CutA and CutB 
proteins. CutA was observed mainly in cytoplasm whereas CutB localised primarily to the 
nucleus, although a significant proportion was found in the cytoplasm (Bharudin, 2017). 
Interestingly, the amount of CutA in nucleus increased when CutB was disrupted (Bharudin, 
2017). Thus, it was postulated that both proteins, CutA and CutB, may shuttle between the 
nucleus and the cytoplasm. 
 
Based on these observations, further analysis was undertaken to check whether CutA and 
CutB are associated with ribosomes, consistent with their proposed role in the regulation of 
transcript functionality and stability.  
 
5.1  CutA and CutB association with ribosomes and their link to Lsm1 
5.1.1  Ribosomal analysis of CutB:S-tag 
CutB was tagged at its C-terminus with the S-tag. This was achieved by homologous 
integration of a linear construct in which the 3’ coding region of cutB was fused to the S-tag 
coding region and Af-pyrG, a selectable marker (Nayak et al., 2005). Downstream for Af-
pyrG was the 3’ UTR of CutB. Putative transformants were screened by PCR to confirm 
integration of the tagging cassette. The resulting CutB:S-tag strain was subjected to Western 
analysis (Figure 5.1.a). Three bands were observed for cutB:S-tag strain, but not with the 
wild-type. The lower doublet had an approximate size of ≥70kDa, which is consistent with 
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the expected size of 77kDa for the CutB protein. The two forms with showing very similar 
migration would be consistent with post-translational modification such as phosphorylation. 
The larger form had an approximate size of ≥100kDa. This may be due to a second isoform 
via different mRNA splicing and/or post-translational modifications (Ahmad et al., 2011). As 
this is a denaturing SDS-PAGE, it is unlikely to be a result of multimerisation. 
 
 
Figure 5.1.a  CutB Western analysis. The whole cell lysates from wild-type (Lane 2) and cutB:S-tag (Lane 1) 
strains were subjected to Western blot using S-tag antibody against CutB:S-tag. Two bands were visualised for 
CutB:S-tag with approximate sizes of ≥70kDa and ≤100kDa. The expected size of CutB is 77kDa. The 
PageRuler™ Plus (Thermo Scientific) protein ladder image taken from the membrane is superimposed on the 
Western blot image in order to estimate the size of protein bands identified (L). 
 
To determine if CutB associates with ribosomes we undertook Western analysis of the 
ribosomal fractions obtained by sucrose density gradient centrifugation. Additionally, we 
investigated the effect of lsm1 deletion to assess if this had an effect on abundance or 
distribution.  In order to do this cutB:S-tag allele was crossed into the ∆lsm1 background. 
cutB:S-tag and Δlsm1 cutB:S-tag strains were cultured in liquid media and prior to 
harvesting were treated with cycloheximide (CHX) for 10 minutes to block ribosome 
elongation and run-off. Cell free extracts were then fractioned using sucrose density 
gradient analysis. The resulting ribosomal profile was monitored by UV absorbance and 
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distinct fractions including polysomes, monosomes and ribosomal subunits were collected. 
The ribosome-associated proteins from gradient fractions were resolved by SDS-PAGE then 
probed with an antibody against the S-tag to determine the presence of CutB in the 
ribosomal fractions. The experiments were performed at least three times, and typical 
results are shown (Figure 5.1.b). Based on our observation, it was found that CutB is 
associated with polysomes, monosomes but the major proportion was associated with the 
40S and 60S ribosomal subunits. This is consistent with CutB putative role in the 
modification of mRNA 3’ end to promote decapping by recruiting the Lsm1-7 complex 
(Morozov et al., 2010). Based on this analysis, it seems that disruption of Lsm1 leads to an 
increase in the accumulation of CutB in the polysomal fraction. This is consistent with there 
being a direct functional link between CutB and the cytoplasmic Lsm complex, which fits 
with the putative role of 3’ tagging in the recruitment of Lsm1-7 complex to initiate mRNA 
degradation (Mullen and Marzluff, 2008). 
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Figure 5.1.b  CutB association with ribosomes. The whole cell lysates from cutB:S-tag and  Δlsm1 cutB:S-tag 
strains were subjected to ribosome profiling using sucrose density centrifugation. Polysomes (Fraction 1), 
disome and trisomes (Fraction 2), monosome (Fraction 3), 60S subunit (Fraction 4) and 40S subunit (Fraction 5) 
and free soluble proteins (Fraction 6) fractions were separated according to size in a 10-50% sucrose gradient 
and the absorbance at 254 nm along the gradient was monitored. Membranes were stained with ponceau red 
to assess gel loading (Top panel) before they were analysed by Western blot with anti-S-tag antibody (Bottom 
panel).Two major bands were visualised for CutB:S-tag with approximate sizes of ≥70kDa and ≤100kDa 
consistent with the Western analysis of whole cell extract control (C). The PageRuler™ Plus (Thermo Scientific) 
protein ladder image taken from the membrane is superimposed on the Western blot image in order to 
estimate the size of protein bands identified (L). 
 
 
 
 
 
 
 
 
 
 
 
 
 
91 
5.1.2  Ribosomal analysis of CutA:S-tag 
Further analysis was undertaken to determine whether CutA was also present in the 
ribosomal fractions. CutA was tagged at its C-terminus with the S-tag. Tagging was achieved 
as described for CutB. The resulting cutA:S-tag strain was subjected to Western analysis to 
confirm the size of CutA (Figure 5.1.c). A major band with an approximate size of ≥100kDa 
was observed for cutA:S-tag strain which contrasts with the expected size of 121kDa. Minor 
bands were also observed which may represent degradation products.  Western analysis of 
protein extracted from polysome fractions gave a band with similar size, based on 
electrophoretic mobility. Surprisingly, CutA:S-tag was only found associated with the 
polysome fraction and not the other ribosomal fractions (Figure 5.1.d). 
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Figure 5.1.c  CutA Western analysis. The whole cell lysates from CutA:S-tag strain was subjected to Western 
blot using S-tag antibody against CutA:S-tag. A band with approximate size of ≤100kDa was observed for 
cutA:S-tag strain. The PageRuler™ Plus (Thermo Scientific) protein ladder image taken from the membrane is 
superimposed on the Western blot image in order to estimate the size of protein bands identified (L). 
 
 
 
Figure 5.1.d  CutA association with ribosomes. The whole cell lysates from cutA:S-tag was subjected to 
ribosome profiling using sucrose density centrifugation. Polysomes (Fraction 1), disome and trisomes (Fraction 
2), monosome (Fraction 3), 60S subunit (Fraction 4), 40S subunit (Fraction 5) and free soluble proteins 
(Fraction 6) fractions were separated according to size in a 10-50% sucrose gradient and the absorbance at 254 
nm along the gradient was monitored. Fractions were analysed by Western blotting using an S-tag antibody 
against CutB:S-tag. One band was visualised for CutA:S-tag with approximate size of ≥100kDa consistent with 
the size observed for CutA using whole cell extract (Figure 5.1.c). The SeeBlue® Plus2 (Thermo Scientific) 
protein ladder image taken from the membrane is superimposed on the Western blot image in order to 
estimate the size of protein bands identified (L). 
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5.2  CutA and CutB interaction 
Pull-down assay was used to determine if there is a physical interaction between CutA and 
CutB. To elucidate their interaction, the cutA:GFP strain was crossed with a cutBS-tag strain 
to construct cutA:GFP cutBS-tag mutant strain. The total cell lysate was incubated with the 
anti-GFP antibody (AB) to immobilise CutA:GFP on agarose beads. The eluted proteins from 
the beads were resolved by SDS-PAGE and an antibody against the S-tag or GFP-tag was 
used as a probe. The pull-down results obtained clearly showed co-immunoprecipitation, 
indicative of an interaction between CutA and CutB proteins (Figure 5.2). However, this was 
very inconsistent with a number of repeat experiments being unsuccessful. Additionally, 
tests in which the samples were treated with RNase prior to precipitation never produced a 
positive result. CutA was not often found in the polysome fraction which was noted during 
multiple CutA polysomal analyses. Combined together, these results indicate that there is a 
possibility that CutA and CutB are engaged with one another but this may not be a direct 
interaction. These results are consistent with imaging of a strain expressing CutA:GFP 
CutB:RFP did not give any clear indication of colocalisation suggesting that it is only a small 
proportion of the two proteins that interact at any one time (Bharudin, 2017). 
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Figure 5.2  CutA  interacts with CutB. Pull-down experiment was performed to determine if CutA:GFP and 
CutB:S-tag interact. Whole cell lysate of cutB:S-tag cutA:GFP strain and cutA:GFP as a control were incubated 
with anti-GFP antibody and  protein A/G agarose beads. The beads were washed and subsequently the 
proteins were eluted from the beads, subjected to SDS-PAGE and transferred onto nitrocellulose membrane. 
The membranes were incubated with the primary antibody: anti S-tag (A) or anti GFP (B). Membranes were 
washed and incubated with HRP coupled secondary antibody and then visualised using ImageQuant LAS 4000 
scanner. One band was visualised for CutB:S-tag with the size of ≤100kDa  (A); and when re-probed with anti-
GFP-tag, the expected bands for CutA at ~130kDa and >130kDa. These data are consistent with the sizes 
observed for CutA and CutB, using cell free extract (Figure 5.1.a and 5.1.c). The PageRuler™ Plus (Thermo 
Scientific) protein ladder image taken from the membrane is superimposed on the Western blot image in 
order to estimate the size of protein bands identified (L). 
 
5.3  The effect of HU on histone mRNA engaged with ribosomes in Δlsm1 and ΔcutA ΔcutB 
NMD relies on translation in order to scan and asses the functionality of transcripts. Through 
this mechanism transcripts with premature termination codons are recognised leading to 
translational repression and degradation, allowing cells to avoid the synthesis of aberrant 
proteins. Translation of mRNA starts with the association of a small ribosomal subunit (40S) 
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and a large ribosomal subunit (60S) to form a complete ribosome (monosome) (Lorsch, 
2013). As the ribosome moves along the mRNA during translation elongation, additional 
ribosomes can initiate translation on the same mRNA forming, polysomes (Lorsch, 2013). 
The rate of translation is reflected in the polysome to monosome ratio (Lorsch, 2013). The 
loss of polysomes results in an associated increase in the number of free 80S ribosomes 
(monosomal peak) (Lorsch, 2013). However, polysomal analysis simply monitors the 
association of ribosomes with an mRNA and this necessarily does not mean that the mRNA 
is translated (Michel and Baranov, 2013). Therefore, ribosomes may be stalled on the 
transcript without generating a protein (Michel and Baranov, 2013). 
 
HU induced histone mRNA degradation data indicated that the disruption of both cutA and 
cutB led to only limited stabilisation of histone mRNA levels (Figure 4.1.a). Moreover, the 
disruption of Lsm1 resulted in an increase in the accumulation of CutB in the polysomal 
fraction (Figure 5.1.b). This suggests a functional link during the translation.  
 
To check the effect of these factors on histone translation and/or ribosome association of 
the transcript after HU treatment, the cells from wild-type, Δlsm1 and ΔcutA ΔcutB strains 
were harvested after both 10 minutes of treatment with CHX (t0), and 10 minutes with HU 
prior to CHX treatment (t20). Ribosome-associated transcripts were separated by sucrose 
density gradient centrifugation. Northern analysis was used subsequently to evaluate the 
relative level of histone transcripts engaged with polysomes, monosomes and ribosomal 
subunits. 
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Figure 5.3.a  Polysomal profile and Northern analysis of the response to HU treatment. Wild-type (WT), 
Δlsm1 and ΔcutA ΔcutB cell cultures were treated 10 minutes with CHX (t0), or 10 minutes with HU prior to 10 
minutes of CHX treatment (t20). Cellular extracts were subject to differential centrifugation and the positions 
of the ribosomal subunits, monosomes and polysomes determined by representative 254 nm absorbance 
profiles (A - D). Each 8 ml gradient was separated into polysomes (Fraction 1), disome and trisomes (Fraction 
2), monosomes (Fraction 3) and ribosomal subunits (Fraction 4). Total RNA was extracted from each fraction 
and resolved by agarose gel electrophoresis and subjected to Northern blot analysis using a probe for H3 
mRNA and 18S RNA (E – G). Bar graph shows calibrated quantitative values for H3 mRNA in each fraction, 
normalising against 18S as a control. n = 3 +/- SD (H – J). 
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Figure 5.3.b  The effect of CutA/B and Lsm1 proteins on translational regulation of histone mRNA in 
response to HU treatment. Graph shows quantitative data based on Northern analysis, giving the relative 
levels of H3 transcripts in the polysomes (Fraction 1), the disome and trisome (Fraction 2), the monosome 
(Fraction 3) and the subunit (Fraction 4) fractions, after a 10 min treatment with HU prior to 10 minutes of CHX 
treatment (t20) compared to 10 minutes of treatment with CHX (t0) in wild-type (WT), Δlsm1 and ΔcutA ΔcutB 
strains. n = 3 +/- SD. 
 
In comparison to the wild-type strain at t0, the cutA cutB double deletion resulted in a 
similar ratio of polysome to monosome fractions (Figure 5.3.a C). Lsm1 deletion had 
reduced polysomal fraction indicative of generally reduced translation (Figure 5.3.a B) 
consistent with the poor growth phenotype. HU treatment in wild-type strain led only to a 
marginal change in the profile, the polysomal proportion decreased relative to the 
monosomal fraction (Figure 5.3.a A). However, the disruption of Lsm1 and CutA/B had little 
effect on their polysomal proportion. Interestingly, in ∆lsm1 strain we observed a noticeably 
high monosomal peak which almost halved at t20, whereas in ∆cutA ∆cutB strain the 
monosomal peak declined slightly. The resulting absorbance profiles reflect the whole 
transcriptome associated with ribosomes. Therefore it is difficult to interpret the effect of 
HU treatment on the absorbance profiles.  
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Northern blot analysis was conducted to monitor any change in the distribution of H3 mRNA 
within the ribosomal profile (Figure 5.3.a). These data were quantified (Figure 5.3.b) and 
this demonstrated a clear change in levels of histone mRNA within polysomes, monosomes 
and ribosomal subunits after HU treatment for the wild-type, which is consistent with the 
reduced level of H3 mRNA observed by Northern analysis after 20 minutes of HU treatment 
(Figure 4.1.a). Interestingly, deletion of Lsm1 resulted in an increase in the proportion of 
transcripts within the monosome and subunit fractions after HU treatment (Figure 5.3.a I). 
Importantly, Northern blot analysis revealed that double deletion of cutA and cutB led to a 
dramatic stabilisation of histone mRNA engaged with polysomes (Fraction 1) (Figure 5.3.a J). 
This supports our previous data, where CutA was found only in the polysome fraction 
(Figure 5.1.d). These data demonstrate the link between the 3’ tagging and the transcripts 
engaged in active translation. 
 
5.4  The effect of CutA/B and Lsm1 on eRF3 association with ribosomes 
In eukaryotes, during translation, eRF3 is recruited to ribosomes stalled at the termination 
codon, by eRF1 (Morozov et al., 2012). The interaction between eRF3 and Pab1 facilitates 
ribosome recycling and the repeated rounds of translation (Morozov et al., 2012). However, 
when translational termination occurs at a premature termination codon, eRF3 is unable to 
interact with Pab1, this allows Upf1 to be recruited (Singh, Rebbapragada and Lykke-
Andersen, 2008) which induces mRNA 3’ tagging in addition to NMD (Morozov et al., 2012). 
NMD induced termination complexes are known to be more recalcitrant than those at a 
native termination codons (Popp and Maquat, 2013), suggesting translational termination 
and/or ribosome recycling are delayed. It has also been proposed that for transcripts that 
have been deadenylated to the threshold length of A15, eRF3 recruited to the terminating 
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ribosome will also be unable to interact with Pab1 and may therefore recruit Upf1, signalling 
mRNA 3’ tagging and promoting rapid degradation (Morozov et al., 2012). This would 
explain the reduced 3’ tagging observed for wild-type transcripts in a ∆upf1 strain (Morozov 
et al., 2012). Again, these termination complexes may be more stable than those present on 
polyadenylated transcripts. 
 
Tagging is known to facilitate removal of NMD substrates from the ribosomes, and possibly 
dissociation of the termination complex. As 3’ tagging is known to help recruit the Lsm1-7 
complex to the transcripts (Mullen and Marzluff, 2008) it is possible that this complex is 
directly involved in dissociation of the termination complex. Thus, it was postulated that the 
disruption of Lsm1, CutA and CutB proteins may result in eRF3, which should be associated 
with the termination complex, being retained for longer by the ribosomes if ribosome 
dissociation is delayed. This also fits the apparent increase in the monosome fraction, which 
may represent the stalled terminating ribosomes. 
 
To test this an eRF3:S-tag strain was constructed by introducing eRF3:S-tag cassette into the 
wild-type strain. This strain was crossed with ∆lsm1 and ∆cutA ∆cutB strains to obtain the 
respective double and triple mutants. Ribosome profiling was conducted using differential 
centrifugation and Western analysis was used to evaluate the abundance of eRF3 engaged 
with ribosomal fractions. Based on our observation, it seems that the amount of eRF3 in the 
polysomal fractions of Δlsm1 and the wild-type is very similar (Figure 5.4). This contrasts 
with our expectations, where we postulated a significant increase in the level of eRF3 in the 
monosomal fraction for the Δlsm1 strain. However, it appears that gel electrophoresis 
pattern for eRF3 in samples derived from the ΔcutA ΔcutB strain is different to those 
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observed for the wild-type and Δlsm1 strains, where the double mutant results in one 
prominent band for the eRF3 in the polysome fraction (Fraction 1). These different forms 
may result from post-translational modification. These data would be consistent with CutA 
and CutB having a role in the transition for translation of a functional transcript to 
translational repression and transcript degradation. Thus further investigation into whether 
this mutation has an effect on eRF3 post translational modification is necessary. 
 
 
Figure 5.4  eRF3 association with ribosomes. Cell extracts from wild-type (WT) eRF3:S-tag, Δlsm1 eRF3:S-tag 
and ΔcutA ΔcutB eRF3:S-tag strains were subject to ribosome profiling using sucrose density centrifugation. 
Polysomes, 80S, 60S and 40S were separated according to size in a 10-50% sucrose gradient and the 
absorbance at 254 nm along the gradient was monitored. Fractions subjected to SDS-PAGE and transferred 
onto nitrocellulose. Membranes were stained with ponceau red to assess gel loading (Top panel) before they 
were analysed by Western blot with anti-S-tag antibody (Bottom panel). The PageRuler™ Plus (Thermo 
Scientific) protein ladder image taken from the membrane is superimposed on the Western blot image in 
order to estimate the size of protein bands identified (L). 
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5.5  Summary 
Three bands were observed for cutB:S-tag strain in Westerns. The lower doublet had an 
approximate size of ≥70kDa, which is consistent with the expected size of 77kDa for the 
CutB protein. The larger form had an approximate size of ≥100kDa which seems to be the 
one interacting with the CutA based on the pull-down assay results. Polysomal analysis 
showed that CutA is only in the polysome fraction whereas CutB was detected in all 
fractions. Compared to wild-type, double deletion of CutA and CutB caused an almost two-
fold increase in stabilisation of histone mRNA engaged with polysomes (Figure 5.3.a). This is 
consistent with previous data, where it has been shown that for transcripts subjected to 
NMD, disruption of 3’ tagging results in transcript accumulation in ribosomal fractions 
obtained by sucrose density gradient (Morozov et al., 2012). This suggests that, disruption 
of tagging results in a delay in ribosomes clearance and possibly histone transcript 
degradation becomes dependent on deadenylation. 
 
Regarding HU induced histone mRNA degradation data it was demonstrated that the 
disruption of CutA and CutB had a low impact on the histone mRNA degradation rate, 
whereas their disruption had a major impact on histone transcripts within polysomes. This 
Suggests that CutA and CutB enzymes are possibly involved in regulating translationally 
active histone transcripts and their disruption results in extension of histone mRNA half-life 
in the polysomes (Figure 5.3.a G and J). 
 
Tagging is known to help recruit the Lsm1-7 complex (Chowdhury, Mukhopadhyay and 
Tharun, 2007) which has been postulated to be directly involved in removal of NMD 
substrates from the ribosomes and dissociation of the termination complex (Morozov et al., 
 
 
 
 
102 
2012). Based on this model, the disruption of Lsm1, CutA and CutB should result in an 
increased level of eRF3 bound to the termination complex in ribosomal fractions. The results 
contrast with our expectations; however, it appeared that the eRF3 in the polysome fraction 
of the ΔcutA ΔcutB strain is different to those observed for the wild-type and Δlsm1 strains. 
This suggests that the tagging factors may have an in/direct role in the post-translational 
modification of eRF3.  
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Chapter 6: Discussion  
6.1  The role of NMD factors in uaZ14 mRNA regulation 
Our results indicated that mutations disrupting the putative NMD factors Upf3 and Smg6 
had a strong effect on the uaZ14 transcript level. This is consistent with their predicted 
function in NMD and similar to mutations disrupting the previously characterised loci, upf1 
and nmdA (upf2) (Morozov et al., 2006). In previous studies in eukaryotes, Smg6 has been 
characterised as an endonuclease that cleaves transcripts harbouring an EJC associated with 
Upf2 and Upf3 proteins downstream from the PTC (Metze et al., 2013). EJC-enhanced NMD 
is a possibility in this case as there are introns positioned 3’ to the PTC in uaZ14 (Morozov et 
al., 2012). Additionally, EJC components have been shown to play an important part in NMD 
for another filamentous ascomycete, N. crassa. 
 
We have shown that both endonuclease cleavage and decapping are essential for NMD in A. 
nidulans, which distinguishes it from S. cerevisiae where decapping is essential.  However, 
this is more like mammalian systems where both decapping and Smg6 cleavage are both 
involved in NMD. It has been shown that the human Smg6 protein cannot bind to mRNA 
itself. Assuming this is the case in A. nidulans, it is highly plausible that phosphorylated Upf1 
recruits Smg6 to the EJC through Upf2 and Upf3, adding extra specificity to the Smg6 
recruitment process (Nicholson et al., 2014).  
 
We found that Upf1 and Smg6 are required for both decapping and cleavage of PTC-
containing uaZ14 transcript. Moreover, our results indicated that both Upf1-K451Q and 
Upf1-RR811AA disrupt NMD, whereas Upf1-C134S had no major effect on uaZ14 mRNA 
stability. K451Q and RR811AA are located in the HD, whereas C134S is located in the CH-
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domain of Upf1. Our results confirm the key role of Upf1 HD is highly likely that Upf1-Smg6 
interaction is required to trigger NMD; the Upf1 HD may be involved in forming this 
complex.  
 
Based on in vitro studies in human cells, Upf1 interacts with CBP80 via its HD to interact 
with the mRNA cap structure (Benhabiles, Jia and Lejeune, 2016). This direct interaction 
with CBP80 promotes the recruitment of Upf1 to the EJC (Hosoda et al., 2005). Additionally, 
Smg1 associated with Smg5-7 and Smg6 (Benhabiles, Jia and Lejeune, 2016). However, 
CBP80 only co-precipitated with Upf1 in the absence of RNaseA, whereas Smg5-7 and Smg6 
were co-precipitated with phosphorylated Upf1 in the presence of RNase A (Okada-
Katsuhata et al., 2011). It was suggested that decapping and endo-cleavage occurs when 
Smg5, Smg6 and Smg7 have all bound to Upf1 and Upf1 ATPase is activated, since Upf1 
ATPase activity may regulate the decapping and Smg6 endonuclease activity (Okada-
Katsuhata et al., 2011). This is consistent with our results where it is possible that a Upf1-
Smg6 association is required for both decapping and Smg6 PIN domain activation for the 
regulation of uaZ14 transcript.  
 
6.2. The role of NMD components in histone mRNA regulation and tagging  
6.2.1. Smg6  
It has been found in various studies amongst eukaryotes that the relative contribution of 
endo- and exo-nucleolytic mRNA decay pathways is variable between transcripts (Metze et 
al., 2013). This is in agreement with our data, where the eliminating components of both the 
5’-3’ and 3’-5’ decay pathways, does not fully overcome but partially reduces the regulatory 
response of histone mRNA to an HU induced block in DNA replication. This indicates that the 
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response is at least partially dependent on transcript degradation and that both 5’ and 3’ 
decay pathways contribute to histone mRNA degradation in A. nidulans. These data are 
consistent with a model in which HU treatment induces rapid histone mRNA degradation 
through both 3’-5’ and 5'-3' pathways in human cells (Mullen and Marzluff, 2008). 
 
In addition to the 5’ and 3’ decay pathways, the enzyme Smg6 has been implicated as an 
endonuclease involved in an alternative deadenylation-independent mRNA decay pathway 
(Nicholson et al., 2014). Endonucleases are particularly potent since they can avoid both the 
5’ cap structure and poly(A) tail that serve as structural mRNA stabilising components. The 
subsequent 5’ and 3’ cleavage products are then degraded in both the 3’-5’ and 5’-3’ 
directions, respectively. 
 
Histone mRNA regulation data presented here indicates that despite the elimination of 
Dcp1, Dcp2, Xrn1 or, components of 3’-5’ exosome complex, mRNA degradation is still 
observed. This potentially underestimates the role of the decapping complex in A. nidulans. 
In addition, the disruption of Smg6 resulted in a dramatic stabilisation of histone mRNA, 
which emphasised the possibility of Smg6 being involved in an endonucleolytic cleavage of 
histone mRNAs. For instance, in D. melanogaster, which lacks Smg7, degradation is mainly 
mediated by the Smg6-mediated endonuclease pathway (Palacios, 2012), where Smg7 is 
believed to link NMD and mRNA decay by interacting with Smg5 and Upf1 (Unterholzner 
and Izaurralde, 2004). Further analysis was undertaken to confirm the role of Smg6 during 
histone mRNA regulation. The results suggested that cleavage of histone transcripts by 
Smg6 was not required as point mutations disrupting the PIN domain did not have an effect 
in either the wild-type or ∆dcp1 background. The role of Smg6 in histone mRNA regulation 
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not being dependent on its nuclease activity would suggest a general role as part of a 
complex involving Upf1. This possibility is in line with the fact that Smg6 may be involved in 
dephosphorylation/phosphorylation cycle of Upf1 (Fukuhara et al., 2005). This clearly 
indicates that the mechanism of histone transcript regulation is different to that of NMD 
although many of the same components are implicated.  
 
In addition to Smg6, recent studies have revealed the novel role of Rrp44 in endo- and exo-
nucleolytic mRNA degradation (Schneider and Tollervey, 2014). Northern data indicates 
Rrp44 had an effect on the histone mRNA stability but not as dramatic as Smg6. Rrp44 is a 
catalytic subunit of the exosome involved in both endonucleolytic and exonucleolytic 
digestions of RNAs (Shoemaker and Green, 2012). It therefore remains a formal possibility 
that endonuclease activity does play some part in histone mRNA degradation. 
 
6.2.2  Upf1 
Phosphorylation of Upf1 as a consequence of replication stress is the starting point for the 
histone mRNA translational termination and subsequent rapid degradation in human cells 
(Choe, Ahn and Kim, 2014). A phosphorylated Upf1 is required as a starting point for mRNA 
decay pathways that have been reported so far (Nicholson et al., 2014). Upf1 binds with its 
N-terminal region rich in CH-domain to C-terminal region of Upf2 which interacts with Upf3 
and thus represents the bridge between Upf1 and Upf3 (Metze et al., 2013). Initial data 
clearly indicates that Upf1, Upf2 and Smg6 are important in the regulation of histone 
transcripts. Our data shows that the Upf1 can have a profound influence on the regulation 
of histone transcripts, although suggesting that other factors may compensate for the role 
of the absent Upf1 in the regulation of histone transcripts in A. nidulans.  
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Upf1 point mutants, C134S, K451Q and RR811AA led to loss of HU induced repression of the 
histone transcripts. This shows that both HD and CH-domain are critical in Upf1 activity. 
However, this contrasts to the effect of these mutations on NMD, where only mutations of 
the Upf1 HD were critical. This indicates that Upf1 functions differently in NMD and histone 
mRNA regulation. 
 
6.2.3  Dhh1 
The interaction between the eIF4G of the cap-binding complex and the Pab1 of the poly(A) 
tail enhances translation and protects the transcript from degradation (Huch and Nissan, 
2014). It has been shown that mutations in the cap-binding complex leads to enhanced 
mRNA decay by increasing the rates of deadenylation and decapping (Huch and Nissan, 
2014). It has been suggested that the replacement of translational initiation factors with 
mRNA decay factors including Dhh1 and Scd6 is an initial step in mRNA degradation (Huch 
and Nissan, 2014). Our results demonstrated that apart from the NMD factors, Dhh1 has the 
strongest effect on histone mRNA levels among the decay factors. It is likely that Dhh1 acts 
upstream of other decay factors by employing additional trans-acting factors that reinforce 
repression and concomitantly stimulate both 5’ and 3’ decay pathways of histone mRNA in 
A. nidulans. For example, the decapping activators Dhh1 and Pat1 are able to interact with 
and recruit deadenylases in yeast and other eukaryotes (Huch and Nissan, 2014). Moreover, 
the deletion of scd6 in A. nidulans displayed a relatively normal morphology, whereas 
deletion of Dhh1 showed a poor growth phenotype (Figure 4.1.b). This may suggest the 
multifunctional role of Dhh1 within and/or outside the NMD complex.  
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In S. cerevisiae, it has been shown that decapping and 5’-3’ degradation of mRNA can occur 
when the transcripts are associated with actively translating ribosomes, in this way, the final 
polypeptide translated is full length and functional before the transcript is destroyed (Hu et 
al., 2009). It has also been proposed that mRNA decapping in vivo occurs predominantly on 
polyribosomes, with the ribosomes blocking the 5′-3′ degradation mediated by Xrn1 (Huch 
and Nissan, 2014). Therefore, preventing further ribosome loading onto transcript seems 
essential to promote mRNA degradation. Furthermore, various studies have shown that 
using the drug CHX blocks the elongation of ribosomes on mRNA which supports a model 
that elongating ribosomes inhibit mRNA degradation (Huch and Nissan, 2014). 
 
Finally, In the HU induced histone mRNA degradation pathway, histone transcript 
degradation occurs because of inhibition of DNA replication and not through the recognition 
of a PTC. Therefore EJCs would be removed by the first round of translation. It has been 
shown that an EJC located approximately thirty nucleotides downstream from the NTC acts 
as an important trans-acting enhancer of NMD (Metze et al., 2013). This is consistent with 
both Upf2 and Upf3 having important roles in NMD as they associate with the EJC. 
Interestingly, our results clearly show that Upf3 is important for NMD-mediated decay 
however, we found that Upf3 does not play a major role in histone mRNA regulation. This 
difference may therefore relate to the absence of a role for the EJC in histone mRNA 
regulation. 
 
6.3  Characterising the role of 3’ tagging 
As previous reports have linked transcript 3’ modification with transcript accelerated 
degradation, it was surprising that the double deletion of CutA and CutB which are 
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responsible for 3’ tagging did not have a daramatic effect on the histone transcript 
regulation. The same has been previously observed with PTC-containing uaZ14 transcript, 
where it was shown that the disruption of CutA or CutB had no inhibiting effect on NMD 
(Morozov et al., 2012).  
 
Our Western analysis data demonstrating that CutA and CutB co-elute with active ribosomal 
fractions. This is consistent with the association of the CutA and CutB enzymes with 
translationally active transcripts. Moreover, the histone mRNA tagging was increased by HU 
treatment in the wild-type strain. Therefore, it is possible that CutA and CutB are involved in 
tagging translationally active histone transcripts. These results are consistent with a model 
in which the tagging factors may interact with the terminating ribosome, to promote the 
engagement of the Lsm1-7 complex which facilitates decapping and translational 
repression. This is consistent with our preliminary data that suggests the ∆cutA ∆cutB 
double deletion has an effect on eRF3 post-translational modification in the polysome 
fraction (Figure 5.4). Moreover, we found that both forms of CutB (≥70kDa and ≤100kDa) 
are engaged with the ribosomes however, only the larger form of CutB was shown to 
interact with CutA (Figure 5.2).  
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Appendix 1a - Buffers and solutions for general molecular biology 
0.5 M disodium EDTA (1 litre): 
168.1 g disodium EDTA 
NaOH (adjust the pH to 8.0) 
 
1X Tris-EDTA (TE) buffer (1 litre): 
0.01 M EDTA, 0.1 M Tris-HCl, pH7.5, autoclave 
 
50X Tris Acetate EDTA buffer (1 litre): 
2 M Tris base, 0.95 M Glacial acetic acid, 100 ml 0.5 M EDTA (pH8.0) 
 
20X Sodium citrate (SSC) buffer (1 litre): 
3 M NaCl, 0.34 M Sodium citrate, pH7.0, autoclave 
 
10X MOPS (1 litre): 
0.2 M MOPS, 0.05 M NaAc, 0.01 M EDTA, autoclave 
 
10X Gel-Loading buffer (RNA electrophoresis): 
50 ml glycerol, 25 ml 1.0 M EDTA (pH8.0), 100 mg bromophenol blue 
 
Appendix 1b - Fungal solutions and media 
Aspergillus Salt Solution (1 litre): 
KCl (0.35 M) 
MgSO4.7H2O (0.1 M) 
KH2PO4 (0.056 M) 
Trace elements solution (50 ml) 
Solution stored at 4˚C 
 
Vitamin solution (1 litre): 
ᵨ-aminobenzoic acid (PABA) (0.003 M) 
Calcium pantothenate (Panto) (0.003 M) 
Pyridoxine (Pyro) (0.001 M) 
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Riboflavin (Ribo) (0.0003 M) 
 
Trace elements solution (1 litre): 
Sodium tetraborate (0.0002 M) 
Cupric sulphate (0.002 M) 
Ferric orthophosphate (0.005 M) 
Manganese sulphate (0.005 M) 
Sodium molybdate (0.004 M) 
Zinc sulphate (0.05 M) 
 
Complete medium (CM) (1 litre): 
Glucose (0.056 M) 
Aspergillus salt solutions (20 ml) 
Vitamin solution (10 ml) 
Yeast extract (0.004 M) 
Peptone (2 g) 
Casamino acids (0.0047 M) 
Adenine (0.0006 M) 
NaOH (adjust pH to 6.5)  
 
Minimum medium (MM) (1 litre): 
Glucose (0.056 M) 
Aspergillus salt solutions (20 ml) 
NaOH (adjust pH to 6.5)  
For solid media, granulated agar was added at either 1% or 3% (w/v) 
All media were autoclaved for 20 minutes at 15 psi and stored at 4˚C 
 
Appendix 1c - SDS-PAGE buffers and gels 
Resolving gel buffer: 
Tris (1.5 M) 
MQ-H2O (make up to 1 litre) 
HCl (adjust pH to 8.8) 
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Stacking gel buffer: 
Tris (0.14 M) 
MQ-H2O (make up to 250 ml) 
HCl (adjust pH to 6.8) 
 
10% SDS: 
SDS (5 g) 
MQ-H2O (make up to 50 ml) 
 
10X SDS electrophoresis buffer: 
Tris (0.25 M) 
Glycine (1.92 M) 
SDS (0.035 M) 
MQ-H2O (make up to 1 litre) 
 
3X loading buffer for precipitated samples: 
187.5 mM Tris-HCl, pH 6.8 
2 % (v/v) SDS 
30 % (v/v) glycerol 
300 mM DTT 
0.06 % (v/v) bromophenol blue 
 
Solubilisation buffer 
50 mM Tris-HCl, pH8.0 
2 % (w/v) SDS 
 
Transfer buffer (1 Litre): 
Glycine (0.192 M) 
Tris (0.025 M) 
Methanol (200 ml) 
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1X TBST buffer (1 litre): 
Tris (0.02 M) 
NaCl (0.15 M) 
HCl (adjust the pH to 7.5) 
Tween® 20 (1 ml) 
 
10% acrylamide gel (1.5 mm glass plate) for SDS-PAGE: 
Resolving gel: 
Acrylamide/Bisacrylamide (2.5 ml) 
Resolving gel buffer (2.5 ml) 
10% SDS (50 µl) 
MQ-H2O (4.9 ml) 
10% APS (100 µl) 
TEMED (10 µl) 
 
Stacking gel: 
Acrylamide/Bisacrylamide (0.66 ml) 
Stacking gel buffer (1.26 ml) 
10% SDS (50 µl) 
MQ-H2O (3 ml) 
10% APS (50 µl) 
TEMED (5 µl) 
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Appendix 2 
 
PCR images of Upf1 mutant gene construction. (A) Two gene fragments with ~25 bp overlapping region were 
produced by PCR for each upf1 mutant allele. (B) DNA bands with the correct size were gel-purified and fused 
together to extend the overlapping region (A1+A2→B1+B2; A3+A4→B3+B4; A5+A6→B5+B6). (L) DNA Ladder 
(Hyperladder1). Primer sequences used in this experiment are listed in Table 2.1.1. 
 
 
Appendix 3 
 
PCR images of Smg6 double mutant gene construction. (A) Two gene fragments with ~25 bp overlapping 
region were produced by PCR for each smg6 mutant allele. (B) DNA bands with the correct size were gel-
purified and fused together (A1+A2→B1 and A3+A4→B2). (C) The two resulting fragments (B1 and B2), each 
containing one of the point mutations were fused together to obtain the full length Smg6 gene with an 
approximate size of 3.5 kbp harbouring both mutations. (L) DNA Ladder (Hyperladder1). Primer sequences 
used in this experiment are listed in Table 2.1.1. 
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